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Abstract 
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Traditional Chinese Medicine Danshen-Gegen Combination Formula Improves 
Atherogenic Pathophysiology: An in-vitro and ex-vivo Study 
Submitted by Chan Yin Ling . 
for the degree of Master of Philosophy in Chinese Medicine 
at The Chinese University of Hong Kong in August, 2006. 
Abstract 
Cardiovascular disease (CVD) is the second most common disease in Hong 
Kong and the leading cause of death in developed countries. Hypertension, 
smoking, hypercholesterolaemia and diabetes have shown to contribute to this 
disease. Atherosclerosis is one of the main causes of CVD. The pathology 
involves oxidation of low density lipoprotein (LDL) by free radicals generated 
in the body, accumulating at the blood vessel wall. These oxidized LDL are 
then engulfed by macrophages to form foam cells. Accumulation of foam cells 
in intima results in plaque development, narrowing of vessel lumens, plaque 
rupture and blockage of blood flow may occur. Therefore, controlling related 
atherosclerotic risk factors and oxidation of LDL are the two foci to prevent 
and relieve CVD. 
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Danshen and Gegen are two Chinese herbs which have long been using in 
Chinese tradition to treat CVD. These two herbs are well-known for exerting 
cardioprotective effects, such as lowering high blood pressure, reducing 
platelet aggregation and suppressing oxidation stress. Previous studies have 
shown that the aqueous extract of Danshen-Gegen (Fenge) in 7:3 ratio 
exhibited potent antioxidative and vasodilative effects which were stronger in 
potency than that of individual herb. In the present study, further optimization 
of the formula was undertaken based on these two pharmacological activities. 
Apart from Fenge, there is another type of Gegen uses in the traditional 
Chinese medicinal application. Hence another type of Gegen, Pueraria Lohata 
(Yege), was investigated as our alternative herb in the formula. Results showed 
that 80% ethanol extract of Danshen-Yege (DY 80) exhibited optimal 
antioxidative effect on AAPH-induced red blood cell hemolysis model and 
vasodilative effect on U46619-precontracted rat aorta rings. 
Results from HPLC analyses revealed the contents of pure compounds in 
DY 80. Vasodilatory and antioxidative effects of these pure compounds were 
subsequently investigated using drug concentration in the range comparable to 
that present in DY 80. Salvianolic acid B (SAB) and daidzein were identified 
as potent vasodilators, which represent the major active ingredients 
» 
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contributing to the vasodilation effect of DY 80 extract. At the same time, SAB 
was found to be the most potent antioxidant which accounted for the majority 
of DY 80's antioxidative activity. Other compounds such as 
protocatechualdehyde, tanshinone IIA and puerarin showed less potent 
antioxidation effect. Furthermore, study of the two compounds purified from 
Yege, 3 ‘ -hydroxypuerarin and 3 ‘ -methoxypuerarin, did not show any 
vasodilatory property. 
The mechanisms underlying the vasodilation action of SAB, daidzein and 
DY 80 were investigated. The results indicated that SAB and DY 80 induced 
endothelium-independent relaxation, while daidzein caused 
endothelium-dependent vessel dilation. Further studies using pharmacological 
blockers demonstrated that SAB and DY 80 mainly acted through the opening 
of K+ channels, resulting in hyperpolarization of smooth muscle cells and 
hence vessel relaxation. The vasodilation effect of daidzein may be mediated 
by multiple actions. It acted through the nitric oxide (NO) and prostacyclin 
pathways, and caused the opening of K+ channels. 
The effects of DY 80 and SAB on Cu^^-induced LDL oxidation were 




conjugated dienes formation and hence inhibited lipid peroxidation. In the 
study of oxidized LDL uptake by macrophages, both DY 80 and SAB 
suppressed the expression of scavenger receptor SR-A on macrophage surface, 
implicating their role in the inhibition of foam cell formation and hence the 
prevention of atherosclerosis. 
In conclusion, the results indicated that the use of Danshen-Gegen formula 
for the prevention and/or treatment of atherosclerosis is supported by its 
pharmacological actions. 
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Chapter 1 
Introduction 
1.1 Introduction to Cardiovascular Disease and Atherosclerosis 
1.1.1 Cardiovascular Disease 
Cardiovascular disease (CVD) is a group of disorders relating to the heart 
and blood vessels, including hypertension (high blood pressure), coronary heart 
disease (heart attack), cerebrovascular disease (stroke), peripheral vascular 
disease, heart failure, rheumatic heart disease, congenital heart disease and 
cardiomyopathies. CVD kills about 17 million people every year worldwide 
and therefore contributes to nearly one-third of the global death (World Health 
Organization, 2004). CVD accounts for 50% of deaths in several developed 
countries. It has long been thought as an affluent countries' disease due to their 
fat-rich diet and sedentary lifestyle. However, 78% of all deaths related to 
CVD occurred in low or middle-income countries, and CVD is affecting more 
and more people in developing countries. One reason for this is the change of 
lifestyle in these developing countries to a more Western one under the 
influence of globalization, accompanied by the adoption of Western diet that is 
- 1 - • 
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high in saturated fats. Another reason is the lack of medical devices or 
dedicated medical support programs for the prevention of CVD, as well as the 
treatment in acute conditions in these countries. 
In Hong Kong, CVD is the second leading cause of death, which account 
for 23.5% of the total death in year 2001 (Hospital Authority of Hong Kong, 
2001), in which heart disease accounts for 14.1% and cerebrovascular disease 
9.4%. This percentage is close to the first leading cause of death for malignant 
neoplasm (34.2%). 
Cardiovascular incidents are not necessarily fatal, but often cause 
impairment of normal lives, requiring long-term medical treatment and 
enormous healthcare costs. Surgical costs for CVD are tremendously expensive. 
However, the recurrence of blockage is high (Ross, 1993). More and more 
factors were being found to increase the chance of getting CVD nowadays. 
Taking precautions on these factors and adoption of a healthy lifestyle would 
reduce these risks. Risk factors of CVD include: (i) cigarette smoking; people 
who quit smoking were found having only half the risk of those who continue 
to smoke, regardless of how long they smoked before quitting. Quitting also 
decreases the risk of death after coronary artery bypass surgery or a heart attack. 
- 2 -
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(ii) diabetes mellitus; glycation of lipoproteins increases the risk of 
atherosclerosis and glycation occurs when blood glucose is elevated (Vlassara 
et al., 1985), (iii) family history, (iv) obesity, (v) physical inactivity and 
unhealthy diet, (vi) increased age and male sex, (vii) folate deficiency, (viii) 
infections, (ix) psychological stress and (x) low birth weight. 
1.1.2 Atherosclerosis 
Atherosclerosis is the primary cause of CVD. "Athero" means gruel or 
paste and "sclerosis" means hardening. It is a process in which deposits of 
lipids, fibrous elements, cellular waste products, calcium and other substances 
build up in the inner lining of an artery. Atherosclerosis is a progressive disease 
which can develop in any artery of the body. However, atherosclerosis usually 
occurs and affects large and medium-sized arteries. Similar pathology 
happened in small arteries are termed "arteriolosclerosis". Atherosclerosis 
affects most frequently the aorta which is the largest blood vessel in the body, 
the coronary arteries, the carotid, the cerebral arteries and also arteries in the 
legs and abdomen. In addition, atherosclerosis occurs more frequently at sites 
of arterial branches. 
- 3 -
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1.1.2.1 Structure of Arteries 
All arteries are comprised of three distinct layers consisting intima, media 
and adventitia, which are separated by internal elastic lamina and external 
elastic lamina, but the proportion of these layers varies with the size and 
function in particular arteries. 
Intima - it is the innermost layer of arteries, it is composed of an endothelial 
layer made up of ellipsoid endothelial cells, overlaying by outlines of 
connective tissue, smooth muscle cells and macrophages may be found in this 
layer. 
Media - it is the middle layer of arteries and it forms the muscular part of the 
arteries walls. It is made up of circularly arranged smooth muscle cells, elastic 
fibers, collagen fibrils and proteoglycans. 
Adventitia — it is the outermost layer and is composed of irregularly arranged 
collagen bundles, scattered fibroblasts, a few elastic fibers and small blood 
vessels (vasa vasorum) which supply the adventitia and the outer media; 
macrophages may also be present in this layer. This fibrous layer allows the 
arteries to stretch but prevent overexpansion of the arteries due to the pressure 
exerted by blood flow, 
- 4 -
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1.1.2.2 Pathophysiology of Atherosclerosis 
Atherosclerosis is a complex and interrelated biological process which 
involves the interaction between numerous cellular elements. This process is 
still not completely understood. However, the "response-to-injury" theory is 
the most widely accepted one (Libby, 2000; Ross, 1993), with lipoproteins or 
other risk factors such as hypertension and cigarette smoking as the injurious 
agents. 
Chot«»t譽fo) aceumulBtion 
霞 a，plaque (nargin* 
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Fig 1.1 Pathophysiology of Atherosclerosis 
(Courtesy from Prof. DS Celermajer) 
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Lesion initiation 
The earliest initiating event in atherogenesis is the accumulation of low 
density lipoprotein (LDL) in the intima. LDL diffuses through the gaps of 
endothelial cells passively. Diffusion and accumulation increases when the 
level of circulating LDL is raised and at preferred sites. Cells in the regions of 
arterial branches, where blood flow is turbulent, show a higher permeability to 
LDL (Gimbrone, 1999). 
Oxidation of Lipoproteins 
LDL accumulated in the vessel wall is oxidized by the reactive oxygen 
species (ROS) or commonly regarded as free radicals in the arteries, to become 
oxidized lipoproteins (oxLDL). Free radicals are formed as a consequence of 
many oxidative biochemical reactions in the body. In addition to the 
environmental free radical sources such as radiation, heavy metals, cigarette 
smoke, alcohol, etc., oxidized lipoproteins are all chemotactic agents, which 
can induce the endothelium to express cell-surface adhesive glycoprotein 
molecules. These glycoproteins then interact with circulating leukocytes, such 
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Macrophase Migration, Foam Cells and Fibrous Plague Formation 
In response to monocyte chemotactic protein (MCP-1), monocytes 
transmigrate across the endothelial monolayer into the intima, where they 
proliferate and differentiate into macrophages and take up the lipoproteins, 
forming the "foam cells". 
Accumulation of foam cells results in yellowish plaque formation in the 
intima, together with the migration and proliferation of smooth muscle cells 
from the medial layer, where they secret fibrous elements, resulting in 
occlusive fibrous plaques which may further increase in size, usually with 
calcification as well. 
Artheriothrombosis 
Advanced lesions of plaque can grow sufficiently large to block the blood 
flow in most atherosclerotic patients. However, the most important clinical 
complication is an acute rupture or erosion of the lesion, with subsequent 
occlusion of lumen due to the formation of a thrombus or blood clot, resulting 
in myocardial infarction or stroke. 
In general, arteries affected with atherosclerosis lose their elasticity and 
reactivity. As the pathological effect of atheroma (plaque) depends largely on 
the degree of luminal narrowing, lesion or thrombus formation in small arteries 
- 7 -
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has more vital clinical significance. In addition, atherosclerotic lesions can start 
at relatively young age (Strong et al., 1999); therefore prevention should be 
taken as early as possible. 
1.1.2.3 Endothelial Dysfunction 
Normal endothelium has homeostatic functions include control over 
thrombosis and platelet, leucocytes interactions, regulation of vascular tone and 
vascular growth (Celermajer, 1997), The endothelium is also dynamic in 
secreting powerful vasodilating (e.g. nitric oxide) and vasoconstricting 
substances (e.g. endothelin-1). Dysfunction of the endothelium is thought to be 
the key event in the early stage of atherosclerosis, and damage of the 
endothelium is crucial to the thrombus formation in advanced atherosclerotic 
lesion. Endothelial injury, either by physical trauma or more subtle cellular 
damage, promotes atherogenic events by promoting lesion and plaque 
formation, increasing adherence of monocytes, increasing permeability to 
monocyte and lipoproteins accumulation in vessel wall, increasing platelet 
adherence and smooth muscle migration and proliferation. Animal models and 
human study clearly demonstrated that the endothelial surface is intact in the 
initial stages of plaque formation. As plaque develops, endothelial denudation, 
- 8 -
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intima tear and rupture commonly occur (Davies et al., 1988), associated with 
implications including impaired endothelium-dependent vessel dilation and 
may induce paradoxical vasoconstriction. Endothelium dysfunction is also 
associated with direct inactivation of nitric oxide by the excess production of 
free radicals, which reduce subsequent bioavailability and action of NO (Cai & 
Harrison, 2000). This situation of endothelial dysfunction was found in patients 
with hypertension, atherosclerosis and congestive heart failure (Luscher & 
Vanhoutte, 1986; Wang et al., 1994). 
Nitric Oxide (NO) 
NO was released by the endothelial cells as a powerful vasodilator in 
response to stimuli in normal endothelial functions. It was synthesized from 
L-arginine by nitric oxide synthase (NOS). In addition to regulating vascular 
tone, NO was demonstrated to have other important roles in the prevention of 
atherosclerosis. NO can inhibit monocyte adherence to endothelial cells, inhibit 
smooth muscle cell chemotaxis and proliferation and inhibit platelet adherence 
and aggregation. NO is also a powerful antioxidant, inhibiting lipid 
peroxidation in LDL (Rubbo et al., 2000; Hogg & Kalyanaraman, 1998). 
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However, hypertension was associated with impaired endothelial release of NO. 
Oxidative stress by free radicals was found to accelerate the breakdown and 
removal of NO, the reduced bioavailability of NO may contribute to the 
initiation and progression of atherogensis. 
Coagulation Fibrinolysis Monocyte 
Platelet interaction adhesion 
A A A 
PGI2 1 NO tPAU PAI-1 Y CAMS 
Endothelial 
cells NO ET-1 VEGF MCP-1 
V V 
Vessel tone Vessel growth 
Smooth -
muscle cells ^ [ ^ 
Fig 1.2 Normal endothelial function. Upward arrows represent factors 
secreted into lumen. Downward arrows represent factors towards smooth 
muscle regulating vascular tone and growth. NO was served as a surrogate 
marker to assess the normal functioning of endothelial layer. (Courtesy from 
Prof. D.S. Celermajer) 
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1.1.3 Current Western Therapies 
1.1.3.1 Surgery 
For treating cardiovascular disease and mainly the coronary artery disease, 
percutaneous transluminal coronary angioplasty (PICA) and coronary artery 
bypass grafting (CABG) are the two principal procedures utilized nowadays. 
Angioplasty 
Balloon angioplasty was first introduced in 1977 by Gruntzig. It is a 
technique used to dilate an area of arterial narrowing with the help of an 
inflatable balloon or a stent of stainless steel wire mesh. Angioplasty is initially 
successful in about 95% of patients. 
Bypass Surgery 
Coronary-bypass surgery was introduced in 1967. Bypass surgery improves 
the blood flow to the heart with a new route, or "bypass," around a section of 
clogged or diseased artery. By 1970, a large number of 13,000 Americans has 
already performed this surgery, among them, 8% died as a result of the surgery. 
Nowadays, the surgical death rate is reduced to 1-3% owing to technical 
refinements. 
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Although both techniques can restore blood flow after surgery, these 
surgical procedures are invasive, costy and skill-demanding, and the recurrence 
rate is high. When balloon angioplasty alone is utilized without stenting, the 
recurrence of the blockage is in the range of 40% in one year. When a stent is 
used, the recurrence of a blockage is in the range of 15 to 20% in one year. 
After bypass surgery, about one-third of the patients will develop a recurrence 
of blockage. These recurrences are due to the inflammation response reacting 
to trauma either at the site of the original atherosclerotic lesion after 
angioplasty, or at the site where normal bypass artery or vein is tied to 
(Anderson, 1992). 
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1.1.3.2 Western Medications 
Western medicines for treating cardiovascular disease have been 
well-studied and utilized for many decades. There are several types of 
medications available in the market nowadays. They work through different 
mechanisms to lower the chance of getting heart attack or stroke. 
Cholesterol lowering agents 
Bile acid sequestrant and statins are the two groups of medicine which both 
aim to lower the cholesterol level in circulating blood. Bile acid sequestrant 
works by enhancing the excretion of bile acids in stool, feedback mechanism 
would make the liver to convert more cholesterol into bile acids. Statins is also 
called HMG-CoA reductase inhibitor. HMG-CoA reductase is the enzyme 
which catalyses the production of endogenous cholesterol. 
Anticoagulants and antiplatelet agents 
These are medicines that reduce blood clotting in arteries. Antiplatelet 
agents such as aspirin, act by inhibiting the production of platelet clumping 
chemicals. Aspirin is the commonest anticoagulant used in controlling acute 
thrombosis in acute coronary syndrome. 
- 1 3 -
» 
Chapter 1 Introduction to Cardiovascular Disease and Atheroslcerosis 
Blockers 
Commonly used blockers include a-adrenergic blockers, P-adrenergic 
blockers and calcium channel blockers, a-adrenergic blockers block the 
receptors in arteries and smooth muscle cells and relax blood vessels. 
P-adrenergic blocker blocks the effect of adrenaline on beta receptors and 
slows down the nerve impulse that travels through the heart and hence the 
pumping force of the heart. Calcium channel blockers slow down the rate at 
which calcium passes into the heart muscle and vessel wall. This relaxes the 
vessels and lowers blood pressure. 
Angiotensin System Inhibitor 
Angiotensin II is the physiologically active form to activate ATI receptors 
to cause vasoconstriction and fluid retention. Angiotensin converting enzyme 
(ACE) inhibitors work by preventing the formation of this active form from 
angiotensin I. And angiotensin receptor antagonists block the action of 
angiotensin II. Both of these actions can increase water loss, lower the blood 
pressure and reduce fibrosis transformation and muscle hypertrophy. 
Diuretics 
These drugs are used to help reduce the amount of salt and water in the 
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body by increasing salt and water excretion in urine, hence lowering the blood 
pressure. 
Adverse Effect 
Although western medicines are effective, they usually have side effects. 
The following list some of the possible side effects of the drugs mentioned. 
Cholesterol-lowerins asents 
These drugs may cause constipation, bloating, heartburn, muscle aches or 
weakness, abdominal pain or discomfort, diarrhea, and nausea, vomiting, 
headache and most importantly, hepatic dysfunction. 
Anticoasulants and antiplatelet asents 
Indigestion is the most common side effect, also gastrointestinal upset 
including nausea, vomiting, heartburn, epigastric or stomach discomfort, or 
ulcers and may increase gastrointestinal bleeding. 
Blockers 
p-adrenergic blockers may cause lethargy, cold hands and feet, nausea, 
nightmares or vivid dreams, and precipitation of asthmatic attack, fatigue, 
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dizziness, headache, depression, impotence and decreased sexual drive. 
a-adrenergic blockers may cause palpitation, dizziness or fainting, especially 
when accompanied by intake of alcohol, cold hands and feet, temporary 
impotence, and nightmares, dizziness, nausea and indigestion. Calcium channel 
blockers can cause headache, facial flush, nausea, tiredness, ankle swelling, 
dizziness, and rash may occur. 
Ansiotensin System Inhibitor 
Common side effects are dizziness or weakness, loss of appetite, rash, 
itching, hacking, persistent cough, and swelling. 
Diuretics 
Although uncommon, lethargy, cramps, rash, or impotence may occur. 
Some of these adverse effects may be related to potassium depletion. 
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1.1.4 Traditional Chinese Medicine 
1.1.4.1 Long History 
Traditional Chinese Medicine (TCM) has a history of over thousands of 
years. It is powerful because of the fact that it is based on the ancestors' trials 
and errors and the results of their experience. Types of TCM include 
acupuncture, remedial massage, herbal medicine and food therapy, Qi Gung 
and meditation. Among them, Chinese herbal medicine is practicing most 
widely in Chinese and other Asian populations, and is becoming more and 
more important in the Western societies. Chinese herbal medicine has been one 
of the greatest herbal systems of the world, and has an unbroken tradition going 
back to the 3rd century BC. The earliest recorded Medica, the Sheng Nung 
Peng Tsao, was written around 2800BC and covered over 300 medicinal 
substances. 
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1.1.4.2 As Alternative Medicine 
Complementary and alternative medicine (CAM), by definition, is a group 
of diverse medical and health care systems, practices, and products that are not 
presently considered to be part of conventional western medicine. Since TCM, 
especially the herbal medicine is increasingly accepted and used by Westerners 
in the US and in European countries like Germany, TCM is now commonly 
regarded as one of the most popular CAM. 
It has been recognized that modem western medicines can effectively treat 
acute or infectious diseases. On the other hand, the strength of traditional 
Chinese medicine is in treating chronic disorders. Herbal medicine is distinct 
from single pharmaceutical drug because of the complexity of plant materials. 
It is more holistic and balanced than medicines based on isolated active 
ingredients and may be less likely to cause side-effects (Kaufman et al., 1999). 
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1.1.4.3 Modernization of Chinese Medicine 
Modernization of TCM has become a new trend in the field. This involves 
using scientific methods to investigate the underlining mechanisms of 
traditional medicines. One important component of this work is to use those 
instrumentation and methodological tools available in Western Science to 
investigate the observations and theories made in traditional Chinese 
medicines. 
Part of it is a growing research body which indicates that the action 
mechanism of traditional herbal medicines could often be explained by modern 
science. On the other hand, modernization could also be made in the 
preparation process of the herbal extracts, that is, with the help of scientific 
research, to optimize the pharmacological value of the tradition medicines. In 
addition, good agriculture practice (GAP) and good manufacture practice 
(GMP) are performed to raise the quality and value of tradition medicines. Also 
formulating traditional Chinese medicine in capsule or by other user-friendly 
preparations would be a part of this process, which save modem people time in 
the complicated preparation of Chinese medicines. 
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1.2 Introduction and Selection of Chinese Medicine 
1.2.1 Selection of TCM Formulation from Pharmacopoeia 
From the Chinese Pharmacopoeia “ Zhong yao fang ji xian dai yan jiu da 
dian" “中藥方劑現代硏究大典”（Huang & Shi, 1996), 28 formulae were 
stated to exert some sorts of cardiovascular tonic effect. Among these, the 
simplest formula that has been used to treat human coronary disease is the one 
that consists of three herbal medicines only. And this formula has been chosen 
previously by my colleague for investigating the cardiotonic effect. The herbal 
medicines included in this formula are Danshen, Gegen and Yanhu, and the 
ratio is in 6:3:1 by weight. 
1.2.1.1 Compound Formulation 
Herbs are typically prescribed in combinations according to Chinese 
tradition. Formulae containing more than one single herb were regarded as 
compound formulation. Compound formulation weights more than single herb 
because the different components of a formulae can balance each other and 
they may undergo a mutual synergy which increases efficacy and enhances 
safety. Therefore, in our study, compound formulation was chosen instead of 
single herb, for the purpose of obtaining a higher efficacy. 
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1.2.2 Introduction to the Herbal Medicines 
1.2.2.1 Danshen (Salvia miltiorrhiza) 
Salvia miltiorrhiza, or called Danshen (丹參）belongs to the Salvia genus, 
which is in the Labiaceae family containing about 1000 species. Among them, 
78 are distributed in China (Wu et al., 1977). Danshen is widely used in the 
Chinese population. According to the therapeutic theory of Chinese medicine, 
Danshen is effective in promoting blood circulation, relieving blood stasis, 
"clearing heat from blood, resolving swelling feeling and tranquilizing the 
mind". In modem scientific study, Danshen was shown to have multiple 
pharmacological activities, for instance, anti-platelet aggregation, 
anti-thrombus formation and improving cardio-cerebral circulation (Chen, 
1984). Other cardioprotective effects include antioxidation (Ji et al., 2003), 
enhancing tissue recovery from anoxia (Cao et al., 2003), anti-atherosclerosis 
(Wu et al” 1998), anti-hypertension (Kang et al., 2002), hepatoprotection 
(Wasser et al., 1998) and anti-tumor effect by inducing apoptosis (Liu et al., 
2000). This herb is currently and empirically used for the treatment of coronary 
heart disease, cerebrovascular disease, hepatitis, hepatocirrhisus, chronic renal 
failure, dysmenorrhea, neurasthenic insomnia (Li, 1998). 
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1.2.2.2 Gegen (Puerariae thomsonii and Puerariae lobata) 
Gegen (葛根)，commercially available in markets and traditional Chinese 
medicine stores, are two different species belong to the same genus Puerariae , 
namely Puerariae thomsonii Benth. and Puerariae lobata (Willd.) Ohwi. Both 
species are regarded as Gegen in traditional medicinal use. However, recently, 
in the 2005 edition of Pharmacopoeia of the People's Republic of China, it has 
been rewritten that Gegen refers to Puerariae lobata (Willd.) Ohwi. only, 
whereas Puerariae thomsonii Benth. is separated out, which is now called 
Fenge instead. 
However, in this study, both species of Gegen were included with reference 
to the formula previously chosen. Gegen is employed commonly to relieve 
fever, promote production of body fluid, facilitate eruption, relieve stiffness 
and pain of the nape (Dictionary of Chinese Traditional Medicine, 1986). 
Gegen was also shown to lower free and esterified cholesterol in modern 
research (Lee et al., 2002). 
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Fenge {Puerariae thomsonii) 
Puerariae thomsonii Benth, or commonly called Fenge (粉葛），is mostly 
cultivated in farms and harvested in the fall and winter, it is mainly grown in 
Guongdong and Guongxi. It contains more starch and is commonly used in 
preparing household soups. Fewer scientific studies have been done on this 
herb. Recent research has shown antidiabetic and lipid metabolism- regulating 
properties (Shen et al., 2006). 
Yege {Puerariae lobata) 
Puerariae lobata (Willd.) Ohwi, or commonly called Yege (里予葛)，grows 
wild in nature, at damp places such as in mid of grassland or at road-sides. 
Yege distributes all over China and is more commonly used in clinical 
applications. More research studies have been done on this herb, and it is 
shown to produce hypocholesterolemic (Yan et al., 2006), antiviral, antioxidant 
(Han et al., 2005) and antitumor effects (Jeon et al., 2005). 
- 2 3 -
I 
Chapter 1 Introduction and Selection of Chinese Medicine 
1.2.2.3 Yanhu {Corydalis yanhusuo) and its Exclusion 
Yanhu (延胡)，species name Corydalis yanhusuo, has been used for 
improving blood flow and relieving painful conditions (Chevallier, 1996). The 
root of this herb is analgesic, antiseptic, antispasmodic and sedative. It is used 
in treatments of disorders including lumbago, dysmenorrhoea, hernia, chest 
pains, insomnia and traumatic injuries (Yeung, 1985; Duke & Ayensu, 1985). 
Exclusion 
Yanhu has mainly the analgesic function, which is, alleviating pain without 
causing loss of consciousness. The inclusion of this herb may lead to the 
consequence of unnoticeable heart attack, which may delay immediate rescue. 
Therefore, for precaution and in order to precisely observe the therapeutic 
effect of the other two herbs in possible clinical trial study, Yanhu has been 
excluded from the combination herbal formula. The formulation hence only 
retains the other two herbs, Danshen and Gegen. 
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1.2.3 Source and Authentication of the Herbal Medicines 
The dried roots of the herbal medicines have been undergone authentication 
before use. Danshen were purchased from local herbal store in Hong Kong 
which were grown in farm with "Good Agriculture Practice (GAP)" at Sichuan 
province. GAP farm provides better quality control about the herbs, but not as 
an absolute guarantee. Dried root of Fenge was purchased from local 
traditional Chinese medicine store and was grown in Guangxi province in 
compliance with GAP. Yege was purchased from Guangzhou. The same 
batches of herbal medicine were used throughout the study to minimize the 
variance due to different sources. All herbal medicines were authenticated by 
an expert Dr. Cao Hui (National Engineering Research Center for 
Modernization of TCM, Zhuhai, Guangdong, China). Morphological 
identification, thin layer chromatography (TLC) and microscopic structure 
identification were utilized to confirm that all herbs are genuine medicinal 
herbs. Voucher numbers for the batches of herbs were as follows. 
Herbal Medicine Voucher no. in storage 
Danshen 2005-2793 
Fenge 2003-2485 
Y ^ 2005-2792 
Table 1.1 Table showing Voucher numbers of Herbal medicines used. 
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Chapter 2 
Optimization of Danshen-Gegen Formula 
2.1 Project History 
After the elimination of Yanhu, the ratio of the remaining two herbs 
Danshen to Gegen was changed into 7:3 by Mr. Ken Leung in his thesis 
entitled "Cardiovascular Tonic Effect of Compound Formula of Radix Salviae 
miltiorrhizae and Radix Puerariae 2003", based on the antioxidant property of 
extracts prepared from a mixture of Danshen and Gegen in different ratios. The 
results showed that Danshen-Gegen in a ratio of 7:3 has the best antioxidation 
effect among other extracts in ratios of 2:1 and 1:1. To mention, Fenge and 
aqueous extract was used in his study. Thereafter, Danshen-Gegen in a ratio of 
7:3 was determined and used in the later studies. 
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2.2 Aims for the Present Study 
As mentioned previously, Gegen have two types, Puerariae lohata (Yege) 
and Puerariae thomsonii (Fenge). In the previous studies, only the latter with 
the combination of Danshen was investigated. However, Yege was found to 
have higher isoflavonoids content than Fenge, which may infer a higher 
bioactivity (Jiang et al.，2005b). To examine this, the extracts of both 
Danshen-Yege and Danshen-Fenge combinations were studied for the 
modification of the formula. 
In addition, the two most commonly used methods for processing 
traditional Chinese medicine are the aqueous extraction and the ethanol 
extraction methods. Aqueous extracts were obtained using water as the 
extraction medium. Compounds extracted in this way are mostly water-soluble, 
hydrophilic substances. However, the water extract yields a large amount of 
polysaccharides and sugar at the same time, which contributes to much weight 
of the dried powders. Ethanol extraction is obtained using ethanol as the 
extraction medium. Ethanol has the tendency to extract non-polar hydrophobic 
substances and less polysaccharides. A study has shown that the ethanol extract 
yielded more active ingredients than the aqueous extract (Zhang et al, 1990). 
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Therefore, in the present study, both ethanol and aqueous extracts of the 
Danshen-Gegen formulation were investigated for the optimization. 
Two pharmacological activities, namely antioxidation and vasodilation, 
both of which are relevant to the pathophysiology of atherosclerosis, were 
examined in the present study. 
Antioxidation property 
It is believed that oxidization of LDL is the precursor in atherogenesis, 
resulting in inflammatory response and plaque formation (Yla-Herttuala et al., 
1989; Carew et al., 1987; Steinberg, 1997). Substances which can deter this 
process and protect against oxidation are believed to possess antioxidation 
property. 
Vasodilation property 
Vasodilation is regarded as a marker for vascular health. Hypertension is 
found a major cause leading to endothelial dysfunction and atherosclerosis. It 
was shown to disrupt endothelial integrity and cause damage of the 
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endothelium (Reidy et al., 1982). Then fibrous plaque formation in the intima 
blocks the normal blood flow in arteries. Occluded vessels would lead to the 
deprivation of oxygen to vital organs and result in irreversible damage to the 
body (Leung et al., 2003; Yee & Schwartz, 1999; Schwartz, 1995). Substances 
which can relax the blood vessels are said to possess vasodilation property. 
Potential vasodilators may help relieve hypertension, by restoring the normal 
functioning of the endothelium, reversing the situation of dysfunction and 
retarding atherogenesis. 
Using antioxidation and vasodilation as monitors, an optimal herbal 
formula was explored in terms of preparation method and active ingredient 
content. 
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2.3 Methods and Materials 
2.3.1 Extracts 
Due to the differential yield of ingredients extracted by different solvents, 
aqueous extract, 50% ethanol extract and 90% ethanol extract of the 
Danshen-Gegen formula were included in the investigation. Aqueous extract is 
used to retrieve water-soluble substances from raw herbs. 90% ethanol tends to 
yield organic compounds. And 50% ethanol extract should yield compounds 
with intermediate polarity. Extracts examined are listed below, all in a Danshen 
to Gegen ratio of 7:3 in dry weight of the raw herbs. 
Extracts Raw herbs (7:3) Extraction Solvent 
DF Aq Danshen- Fenge Distilled water 
DF 50 Danshen- Fenge 50% Ethanol 
DF 90 Danshen- Fenge 90% Ethanol 
DY Aq Danshen- Yege Distilled water 
DY 50 Danshen- Yege 50% Ethanol 
DY 90 Danshen- Yege 90% Ethanol 
Table 2.1 Extracts used in formula optimization with different herbal 
constituents and extraction solvents shown. 
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2.3.2 Extraction Process 
Reflux Boiling 
Raw herbs were washed gently with tap water to remove mud and other 
contaminants. Dried roots were then cut into small pieces. Proper proportions 
of Danshen and Fenge or Yege were weighed and extracted with the 
appropriate solvent in a ratio of 1:10 (weight/volume) under reflux for 1 hour. 
The extract was collected and left until cool. Residues were then subjected to 
two more subsequent extractions under the same condition for 1 hour and then 
0.5 hour. All extracts were pooled and constituted the decoction. 
Filtration 
The cooled decoction was centrifuged at 7,700 g for 20 minutes and the 
supernatant was filtered through Walter No.l filter paper under suction. 
Evaporation and Lyophilization 
The supernatant was concentrated by rotary evaporator under reduced 
pressure at 60�C. As for the ethanol extracts, they were evaporated to complete 
dryness and the extracts were kept in a warmed vacuum desiccator with sodium 
- 3 1 -
Chapter 2 Optimization of Danshen-Gegen Formula 
hydroxide for 2 days. The concentrated aqueous extract was dried by 
lyophilization. The dried powder of all extracts was finally collected and kept 
in the desiccator until use. 
Extraction Yield 
Extracts Percentage yield (w/w) 
DF Aq 40.5% 
DF 50 32.7% 
DF 90 7.2% 
DYAq 55.2% 
DY 50 16.4% 
DY 90 
Table 2.2 Extraction yield of the six extracts shown in percentage. 
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2.3.3 In vitro Antioxidation Model 
AAPH-induced Red Blood Cell Hemolysis Model 
2,2‘-azobis-(2-amidinopropane) dihydrochloride (AAPH) is a water-soluble 
azo compound which undergoes thermal decomposition to produce 
carbon-centered free radicals. It has been widely used as a free radical 
generator in the study of characterization of antioxidants (Niki et al., 1988). 
The antioxidative capacities of compounds were compared by measuring the 
inhibition of AAPH-induced hemolysis. 
Animals 
Male Sprague-Dawley (SD) rats of 320-350g were bred and kept by the 
Laboratory Animal Services Center of the Chinese University of Hong Kong. 
All procedures in animal studies have been approved by the Ethical Committee 
of Animal Studies of the Chinese University of Hong Kong. 
Red Blood Cell Suspension Preparation 
Rat was anesthetized by ether and blood was collected from the renal vein 
into heparin-containing tube, then centrifuged at 1500 x g for 10 minutes. 
Supernatant was discarded. Remaining red blood cells (RBCs) was washed 
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twice with 0.15M NaCl solution. RBCs were collected by centrifuging at 1000 
X g for 10 minutes in the last step. Supernatant was discarded. 5 fold dilution 
was obtained by adding phosphate-buffered saline (PBS) to the RBCs, 
resulting in a 20% suspension. 
Cell Lysis Reaction 
Extracts were weighed and dissolved in PBS or 10% Dimethyl sulfoxide 
(DMSO). Two-fold serial dilutions with PBS were made to obtain a range of 
different concentrations of the extracts. Reaction mixtures contain a final 
concentration of 10% red blood cell suspension, lOOmM AAPH and different 
concentrations of extracts. Control was done by adding PBS or 0.25% DMSO. 
AAPH was added just before the reaction started. The reaction mixtures were 
then kept in dark, incubated at 37®C with oscillation for 200 minutes. 
Inhibition on Red Cell Lysis 
After incubation, each reaction mixture was diluted 20 folds in PBS and 
distilled water respectively. The diluted mixtures were then centrifuged at 1500 
X g for 10 minutes. Supernatant of each reaction tubes was transferred to 
flat-bottom 96-well plates. Absorbance at 540nm was measured by ELISA 
plate reader. The percentage of inhibition on the red blood cell hemolysis by 
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each extract was calculated by the following formula: 
^ — 
Inhibition % = D W . a m p l e - P B S 哪 丨 。 _ DWcontrol - PBScontrol X 100% 
� DWsample DWcontrol � 
The 50% Inhibition Concentration (IC50) was used as an index to compare 
the antioxidative potency of the test compounds. The lower the IC50 represents 
a higher antioxidative potency of the compound. 
2.3.4 Ex vivo Vasodilation Model 
Chemicals 
R(-)-phenylephrine hydrochloride (Phe), acetylcholine chloride (Ach) and 
9,11 -dideoxy-9a, 11 a-methanoepoxy prostaglandin (U46619) were supplied 
by Sigma. Krebs solution (118.0 mM NaCl, 4.7 mM KCl, 1.64 mM MgSCU, 
1.2 mM KH2PO4, 5.55 mM D-glucose, 25.0 mM NaHCOs and 2.5 mM CaCb) 
with pH 7.4 was prepared and filtered. 
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Animals 
Male Sprague-Dawley rats of 280-300g were bred and kept by the 
Laboratory Animal Services Center of the Chinese University of Hong Kong. 
All procedures in animal studies have been approved by the Ethical Committee 
of Animal Studies of the Chinese University of Hong Kong. 
Aorta Isolation 
Rat weighing around 300g was sacrified by cervical dislocation. The aorta 
was isolated out and soaked in gased cold Krebs solution. After fat and 
connective tissues were removed, the aorta was cut into 2 mm rings. The aorta 
rings were then mounted between steel wire hooks and placed into the organ 
bath. The condition was maintained at 37°C in Krebs solution and gassed with 
mixture of 95% O2 and 5% CO2. The aorta rings were equilibrated for 1 hour, 
replacing fresh Krebs solution at every 20 minutes interval. And the tension of 
the rings was gradually increased to 1.5g as the baseline tension. 
Aorta Normal Functioning Test 
The integrity of the aorta rings was verified before experiments. Aorta rings 
were first contracted with 0.3 |xM Phe, waited for 15 minutes until stabilized, 
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0.3 |xM Ach was then added to relax the aorta rings back to initial baseline 
tension of 1.5g. Ach mediates an endothelial-dependent relaxation. Aorta rings 
showing relaxations of 80% or more compared with the Phe-induced 
contraction tone were used for further drug tests. Those with damaged 
endothelium were excluded. Aorta rings were then washed and equilibrated 
again for an hour with successive washing by Krebs solution before drug tests. 
Drug Test 
U46619 (15 nM) was added to induce contraction of the aorta rings, waited 
until maximal tension has been reached and sustained. The herbal extracts were 
then added into the organ baths and the tension was recorded by MacLab data 
acquisition system through Grass force-displacement transducers FT-03E. 
Herbal extracts were dissolved in Krebs solution. Dimethyl sulfoxide (DMSO) 
was used to dissolve extracts which are not soluble in Krebs solution, with a 
final concentration not more than 0.3% in the organ baths. 
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2.3.5 Statistical Analysis 
All data was shown in mean 土 SD. Groups were compared by one way 
ANOVA with Bonferroni post hoc test analyzed for pairway comparisons and 
linearity except specified. Statistical significance was inferred at a two sided 
value of P<0.05. GraphPad Prism version 4.00 for window was used for 
statistical analysis. 
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2.4 Results 
2.4.1 Vasodilation Results 
The vasodilation response of the six extracts was compared. In figure 2.1, 
both 90% ethanol extract of Danshen-Fenge and Danshen-Yege combination 
showed significant vasodilative effect, which was more potent than their 
aqueous and 50% ethanol extract counterparts. The latter two did not show 
significant difference in their vasodilative properties. The difference between 
the 90% ethanol and aqueous extracts was more obvious in the Danshen-Yege 
combination. 
In figure 2.2, when the combinations of Danshen-Fenge and Danshen-Yege 
were compared, it was found that the Danshen-Yege extracts generally 
exhibited a more potent vasodilation response than that of the Danshen-Fenge 
extracts. The difference in vasodilatory response between the two groups of 
extracts was significant in their 90% ethanol extracts. 
In figure 2.3, when all the six extracts of DF Aq, DF 50, DF 90, DY Aq, 
DY 50 and DY 90 were compared, it was obvious that 90% ethanol extract of 
Danshen-Yege combination was significantly more potent in vasodilation 
response than all the other extracts. Therefore it was the most potent 
vasodilator among the extracts studied. 
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Fig 2.1 Vasodilatory Effect of Aqueous extract versus Ethanol extract of 
Danshen-Fenge (DF) and Danshen-Yege (DY). All extracts were 
administered at Time 0 of 4mg/ml to U46619-precontrated aorta rings, (a) 
Vasodilation response of DF Aq, DF 50 and DF 90. Effectiveness of dilating 
effect increased accordingly as DF 50, DF Aq and DF 90. Data were shown as 
mean 土 SD (n=6), * P< 0.05，DF 90 versus DF 50. (h) Vasodilation response 
ofDYAq, DY50 and DY90. Data were shown as mean 土 SD (n二6)，* P< 0.01’ 
DY 90 versus DY Aq and DY 50. Effectiveness of dilating effect increased 
accordingly as DYAq, DY 50 and DY 90. 
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Fig 2.2 Vasodilatory Effect of Danshen-Fenge (DF) versus Danshen-Yege 
(DY). (a) Vasodilation response of DF Aq and DY Aq. (h) Vasodilation 
response of DF 50 and DY 50. (c) Vasodilation response of DF 90 and DY 90. 
All data were presented in mean 土 SD (n=6). Student t-test was used to 
determine the confident limits between two groups. * P<0.05 
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Fig 2.3 Vasodilation Effect of the herbal extracts on U46619-precontracted 
aorta rings. The results were presented in percentage of relaxation induced by 
drug in the time-course experiment. The concentration of the drugs added were 
4mg/ml Time 0 is defined as the time when drugs were added to the organ 
baths. Data were shown in mean 土 SD (n=6). * P<0.05, DY 90 versus other 
extracts. The effectiveness of the drugs on vasodilative response increases 
accordingly as DF 50, DFAq, DYAq, DY50, DF90andDY90. 
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2.4.2 Antioxidation Results 
Antioxidation effects of the six extracts were compared in figure 2.4. 50% 
ethanol extract of Danshen-Yege, 50% and 90% ethanol extracts of 
Danshen-Fenge exhibited similar antioxidation activities and were more potent 
antioxidants than the other extracts, indicated by IC50 value of the extracts in 
table 2.3. The three extracts, DY 50, DF 50 and DF 90, had the lowest IC50 
values (196, 197 and 195 |ig/ml respectively) compared with the others. 
Aqueous extracts of Danshen-Fenge and Danshen-Yege combinations showed 
a less potent antioxidant effect. However, 90% ethanol extract of 
Danshen-Yege had a marked reduction in antioxidation activity, with the IC50 
value being 782 )ig/ml. 
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Fig 2.4 Inhibitory Effect of the herbal extracts on AAPH-induced Red 
Blood Cell Hemolysis. Results were expressed in the percentage of protective 
effect of the drugs on AAPH-induced red cells hemolysis. Different dosages of 
drugs were administered. Vitamin C was used as the positive control Data 
were expressed as mean 土 SD (n=8).沒 P<0.05, DF 50，DF 90 and DY 50 
versus other extracts.枯 P<0.05, DY 90 versus other extracts. The antioxidant 
effect of the extracts increased accordingly as DF 50, DF 90, DY 50�DF Aq, 
DYAq > DY90. 
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Extracts IC50(/zg/ml) 
DF Aq 322 
DF 50 197 
DF 90 195 
DYAq 391 
DY50 196 
DY 90 782 
Ascorbic acid (Vit. C) ^  
Table 2.3 Comparison of IC50 values of the herbal extracts and Ascorbic 
acid. The protective effect of the extracts on inhibiting red cell hemolysis was 
compared by IC50 values. IC50 value was obtained by calculating the drug 
concentration when 50% of inhibition was reached. Unit of IC5() was 
expressed as /ug/ml here. Lower IC50 represents a higher activity of the tested 
substances. Vitamin C was the positive control. Extracts DY 50, DF 50 and DF 
90 have similar IC50 values of 196, 197 and 195 /ug/ml respectively. DY 90 has 
the highest IC50 of 782 jug/ml. 
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2.5 Discussion 
In the present study, six extracts of DF Aq, DF 50, DF 90, DY Aq, DY 50 
and DY 90 were assessed by their vasodilation and antioxidation properties for 
optimizing the Danshen-Gegen formula, used in preventing atherogenesis and 
treating cardiovascular disease. 
Aqueous and 50% ethanol extracts of both Danshen-Fenge and 
Danshen-Yege combinations did not show significant difference in the 
vasodilation activity, implicating that the constituents extracted by water and 
50% ethanol were similar in composition and polarities. However, at a high 
ethanol percentage of 90%, it is possible that more active ingredients for 
vasodilation were extracted from the raw herbs, as evidenced by a higher 
bioactivity of the extract. This result is consistent with some previous studies 
which indicated that ethanol was a more efficient solvent for the extraction of 
herbs (Zhang et al., 1990; Zhao et al., 2004; Ugochukwu et al., 2003; Savickas 
et al., 2004). Danshen-Yege combination exhibited a higher potency in 
vasodilation effect than Danshen-Fenge combination, implying that Yege in 
general contains more active components than Fenge. A recent study has 
reported a similar finding that Yege has a higher isoflavonoid content, inferring 
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a higher bioactivity than that of Fenge (Jiang et al., 2005b). It is also possible 
that Yege may possess substances which can enhance the solubility or the 
vasodilatory activity of active components from Danshen. Further study is 
needed to confirm this. From the present study, the active compounds for 
vasodilation activity present in Yege were extracted in a greater amount by a 
higher ethanol concentration. The 90% ethanol extract of Danshen-Yege 
combination was found to be the most potent in exerting vasodilation effect. In 
contrast, this extract showed the weakest effect in antioxidative activity. 
Instead, DY 50, DF 50 and DF 90 possessed more potent antioxidative effects 
than DY 90. Nevertheless, it is still possible that the ethanol extraction can 
yield more antioxidant compounds than the aqueous extraction. On the other 
hand, this different potency in vasodilatory and antioxidant effects (in opposite 
direction) in different extracts would argue against the pure mass effects of 
inert polysaccharides extracted out by aqueous and 50% ethanol solvent, and 
less so in 90% ethanol solvent. This would be reconfirmed in later chapter, 
after evaluating the concentration of active compounds. 
Based on the findings that, (i) ethanol extract possessed more active 
components; (ii) Yege had a higher vasodilation activity; (iii) DY 90 exhibited 
the most potent vasodilation response and (iv) DY 50 had the strongest 
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antioxidant effect, similar to those of DF 50 and DF 90. The optimized formula 
may somehow be obtained by the extraction of Danshen-Yege mixture using 
ethanol with percentages ranging from 50 to 90%. Therefore, further studies 
should compare the 60%, 70% and 80% ethanol extracts of the Danshen-Yege 
combination. 
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2.6 Further Modification of the Formula 
2.6.1 Extracts 
Extracts Raw Materials (7:3) Extraction Solvent Percentage Yield 
DY 60 Danshen-Yege 60% Ethanol 28.5% 
DY 70 Danshen-Yege 70% Ethanol 23.7% 
DY 80 Danshen-Yege 80% Ethanol 16.4% 
Table 2.4 Extracts for further optimization with different ethanol 
concentrations as solvents and percentage yields shown. 
2.6.2 Results 
Same vasodilation and antioxidation assays used in previous experiments 
were utilized for the present study. In figure 2.5 and 2.6, vasodilatory and 
antioxidant activities of 60%, 70% and 80% ethanol extracts of Danshen-Yege 
combination were compared. Vasodilation responses of the extracts increased 
when raising the ethanol percentage from 60% to 80%. DY 80 exerted a 
significantly higher vasodilative effect compared with DY 60. Similarly, the 
antioxidant effect was enhanced by increasing ethanol percentage during 
extraction. DY 80 showed a significantly stronger antioxidant effect than those 
of DY 60 and DY 70 extracts, having the lowest IC 50 of 102 jig/ml (table 2.5). 
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Fig 2.5 Vasodilatory Effect of DY 60，DY 70 and DY 80 on 
U46619-precontracted aorta rings. Data were expressed in percentage of 
relaxation induced by drug added to the pre-contracted aorta ring in a time 
course experiment. Data were shown as mean 土 SD (n=7). * P<0.05 DY 80 
versus DY 60. Vasodilative response was enhanced by higher ethanol 
percentage in solvent during extraction. Effectiveness of dilation increased 
accordingly as DY 60, DY 70 and DY80. 
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Fig 2.6 Inhibitory Effect of DY 60，DY 70 and DY 80 on AAPH-induced 
Red Blood Cell Hemolysis. Results were expressed as the percentage of 
protective effect of the drugs on AAPH-induced red blood cells hemolysis. 
Vitamin C was used as a positive control. Data were expressed as mean 土 SD 
(n=6). ^ P<0.05’ DY 80 versus DY 60 and DY 70. Inhibitory effect increased 
with higher ethanol percentages in the solvent during extraction in descending 
order as DY80 >DY70> DY60. 
Extracts IC50(//g/ml) 
DY 60 151 
DY 70 134 
DY 80 102 
Ascorbic acid (Vit. C) 93 
Table 2.5 Comparison of IC50 values of DY 60，DY 70, DY 80 and 
Ascorbic acid. IC50 was obtained by calculating the drug concentration when 
50% of inhibition was reached. Unit of IC50 was expressed as jug/ml here. 
Lower IC50 represents a higher inhibitory activity of the tested substances. 
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2.7 Discussion 
Vascular contraction is mediated by vascular smooth muscle (VSM) cells. 
VSM undergoes slow, sustained, tonic contractions. Contraction of VSM can 
be initiated by mechanical, electrical, and chemical stimuli. Opening of the 
voltage-gated calcium channels causes the depolarization of the VSM cell 
membrane and hence contraction. Vasoconstrictors, including norepinephrine, 
vasopressin, thromboxane A2 and endothelin-1, initiate contraction via 
increasing the intracellular calcium level. 
U46619, used for the precontraction of the aorta rings, is a prostaglandin 
endoperoxide analog which serves as a thromboxane A2 (TxA2) mimetic that 
causes vasoconstriction (Burch & Halushka, 1983). Hence the change in the 
contracted tone could be utilized for the determination of the vasodilation 
properties of certain substances. 
Free radicals are natural by-products generated in many processes within 
and among cells. They are also created by the exposure to various 
environmental factors such as tobacco smoke and radiations. Free radicals 
include hydroxyl radical ( OH), reactive oxygen species (ROS) such as 
hydrogen peroxide (H2O2) and superoxide anion (O2 "). These molecules are 
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unstable and highly reactive, damaging cells by chemical chain reactions such 
as lipid peroxidation, which plays a precursor role in atherogenesis, or 
formation of DNA adducts that could cause cancer-promoting mutations or cell 
deaths (Finkel & Holbrook, 2000). The major function of antioxidants is to 
prevent the damages due to the actions of ROS and free radicals. All cells 
contain antioxidants that serve this purpose. Dietary antioxidants, therefore, are 
not the primary antioxidant inside the body, but serve as an external source 
against the action of free radicals. There are still many questions of how these 
dietary antioxidants protect cells from oxidation. Some antioxidants were 
found to preserve, or even recycle, other antioxidants such as vitamin E. Other 
antioxidants may have far-reaching effects, such as modulating the insulin 
actions, which is not clearly understood (Nordberg & Amer, 2001). 
To the benefits of preventing atherosclerosis, antioxidants can lower the 
level of cholesterol being oxidized and hence deter the plaque formation and 
sustain normal blood flow in body. Biomembranes are rich in polyunsaturated 
fatty acids which are susceptible to the free radical mediated peroxidation. It 
was shown that low antioxidant status of the erythrocytes membrane increases 
its susceptibility to hemolysis (Delmas-Beauvieux et al., 1995). AAPH 
generates free radicals that attack erythrocyte membrane lipids, resulting in 
lipid peroxidation and eventually hemolysis. This model provides a good way 
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to evaluate the antioxidative potential of certain substances by examining their 
inhibitory effect on hemolysis (Niki et al., 1988). 
Identification of vasodilators that can restore the vessel dilation function 
and antioxidants that can reduce oxidative stress, both serve as markers of 
vascular health, would potentially contribute to the treatment of atherosclerosis. 
The 80% ethanol extract of Danshen-Yege has been demonstrated to be the 
most potent in both vasodilation and antioxidation activities. The present study 
also reconfirmed that the increase in ethanol percentage during extraction could 
enhance the extract's activity, both in vasodilation and antioxidation. The 
extract may be therefore used for retarding the progression of atherogenesis 
and/or preventing the pathogenesis of the disease. 
An interesting point to be noted in the modification process of the herbal 
formula is the solubility of the extract powders, which is also important to be 
considered, both in facilitating the experimental procedures and for easy 
consumption as well. In our study, since DY 90 extract contained mostly highly 
hydrophobic compounds, organic solvent (DMSO) was required for dissolving 
the extract powders before the administration in experiments. However, the 
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extracts obtained by 80% or lower ethanol percentage in the extraction process 
were found soluble in water. This leads to much convenience in the dissolving 
process and adds value to the optimized formulation for later applications. 
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Chapter 3 
Marker Chemical Contents of Herbal Extracts and their 
Pharmacological Properties 
3.1 HPLC Analysis of Marker Contents 
To correlate the pharmacological activities of herbal extracts used in 
Chapter 2, marker compounds, including protocatechualdehyde, puerarin, 
daidzin, salvianolic acid B, daidzein and tanshinone IIA, were measured in DY 
50, DY 60, DY 70, DY 80 and DY 90 extracts using HPLC method. Moreover, 
the difference in marker contents of the extracts by raising the percentage of 
ethanol in the extraction process was compared. 
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3.1.1 Methods 
Calibration curves were constructed using standard marker compounds. 
Herbal extract samples (lOmg/ml) were dissolved in 15% ACN: 85% H2O and 
the solutions were filtered and injected into Beckman Ultrasphere ODS, 5|j., 
4.6mm x 250mm column via autosampler vials. The mobile phase was A: 0.5% 
acetic acid and B: ACN. A gradient profile was utilized to obtain the 
chromatogram. The method used was 0-25min:5-50%B, 25-30min:50-90%B, 
30-40min:90%B, 40-45min:90-5%B and finally 45-50min:5%B. Detection 
wavelengths were set at 254 and 280nm. Samples were measured in triplicate 
and the content of the respective markers was estimated from the standard 
calibration curve. 
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3.1.2 Results 
HPLC chromatograms and the concentrations of various markers in the 
extracts were examined in the present study. Retention times of the six markers 
were identified in figure 3.1, which were used for identifying the compounds in 
HPLC chromatograms of the extracts (figure 3.2 - 3.6). It was shown in the 
HPLC chromatograms that the contents of the marker compounds (puerarin, 
daidzin, daidzein and tanshinone IIA) generally increased as the ethanol 
percentage was raised in the extraction process. 
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3.1.2.1 HPLC Chromatograms 
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Fig. 3.1 HPLC Chromatogram of a mixure containing six marker 
compounds. A mixture of markers with concentrations at 50ppm was shown in 
this figure. The peaks and retention times of the six markers were identified. 
Retention times for protocatechualdehyde, puerarin, daidzin, salvianolic acid B, 
daidzein and tanshinone IIA were identified approximately as 12.2，J 3.2, 14.5, 
19.0, 21.0 and 35.2 min, respectively. 
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Fig. 3.2 HPLC Chromatogram of DY 50 Extract. The peaks and retention 
times of the six markers were shown. The detection was monitored at 254nm. 
One out of three triplicates was shown here. 
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Fig. 3.3 HPLC Chromatogram of DY 60 Extract. The peaks and retention 
times of the six markers were shown. The detection was monitored at 254nm. 
One out of three triplicates was shown here. 
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Fig. 3.4 HPLC Chromatogram of DY 70 Extract. The peaks and retention 
times of the six markers were shown. The detection was monitored at 254nm. 
One out of three triplicates was shown here. 
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Fig. 3.5 HPLC Chromatogram of DY 80 Extract. The peaks and retention 
times of the six markers were shown. The detection was monitored at 254nm. 
One out of three triplicates was shown here. 
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Fig. 3.6 HPLC Chromatogram of DY 90 Extract. The peaks and retention 
times of the six markers were shown. The detection was monitored at 254nm. 
One out of three triplicates was shown here. 
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3.1.2.2 Content Percentage of Marker Compounds 
The six marker compounds were quantified in various herbal extracts. 
Contents of the markers in the extracts were estimated by substituting into 
standard calibration curves. In Table 3.1，puerarin, daidzin, daidzein and 
tanshinone IIA were increased in extracts obtained from increasing 
concentrations of ethanol. However, protocatechualdehyde and salvianolic acid 
B showed a drastic drop in DY 90 extract, in- spite of the ethanol 
concentration(50-80%)-dependent increase. 
Markers Extracts 
DY50 1 DY60 ] DY 70 DY 80 DY 90 
Protocatechualdehyde 0.047% 0.22% 0.29% 0.44% 0.089% 
Puerarin 2.19% 2.4% 3.02% 4.7% 13.67% 
Daidzin 0.55% 0.55% 0.7% 1.08% 1.94% 
Salvianolic acid B 2.61% 4.62% 5.28% 6.11% 1.33% 
Daidzein 0.027% 0.042% 0.081% 0.14% 0.4% 
Tanshinone IIA 0.094% 0.14% 0.22% 0.4% 1.2o/o 
Table 3.1 Contents of marker compounds in the different herbal extracts. 
The contents were expressed in percentage (w/w). Each data was obtained by 
taking the average from triplicate trials. 
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3.1.3 Discussion 
The six markers (protocatechualdehyde, puerarin, daidzin, salvianolic acid 
B, daidzein and tanshinone IIA) used in this HPLC study are the most 
commonly investigated marker compounds in Danshen and Gegen. From the 
HPLC analyses of various herbal extracts, the contents of all marker 
compounds were increased by a higher concentration of ethanol used in the 
extraction. Yet with the exception in DY 90’ as the content of salvianolic acid B 
and protocatechualdehyde have dropped suddenly. This may be due to the fact 
that the highly non-polar 90% ethanol solvent was failed to extract these two 
water-soluble substances. The findings in this part will be further elucidated, 
after identifying the active components for the vasodilation and antioxidation 
properties of the Danshen-Gegen formula. 
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3.2 Studies on Marker Compounds 
3.2.1 Introduction 
As mentioned earlier, one crucial element in TCM modernization is the 
understanding of the mechanism of how these herbal medicines work. Chinese 
medicine has been in use for thousands of years, but the scientific study on its 
biochemical actions just started in recent decades. Herbal extracts differ from 
western pharmaceutical drugs in ways that they contain numerous compounds 
in one plant, whereas the latter is usually composed of one single active 
chemical. In order to study how an herbal extract works, it is essential to study 
its pure active compounds. However, a single herb may contain hundreds or 
thousands of different compounds and they may work together to exert the 
maximum therapeutic effect. Some compounds were attracting more interest 
than the others because of their specific chemical structures. For example, 
phenolic compounds were found to be putative antioxidants due to its capacity 
to delocalize the electron of free radicals. 
Danshen was found to be rich in polyphenolic compounds (Zhang et al., 
2005). The most abundant group being the caffeic acid and its derivatives, with 
biological activities including antioxidant, anti-ischemia reperfusion, 
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anti-thrombosis, anti-hypertension, anti-fibrosis, antivirus and antitumor 
properties (Jiang et al., 2005b). On the other hand, previous studies on Yege 
have reported a number of bioactive isoflavones (Fang et al, 1974). Flavonoids 
comprise a large group of polyphenolic compounds (Kuehnau, 1976). Most 
flavonoids have been reported to modulate vascular tone, exert antioxidation 
effect and reduce LDL-cholesterol (Chan, et al, 2000; Ajay et al, 2003). Other 
biological activities of flavonoids include anti-inflammatory (Rahman et al., 
2003), anti-angiogenic, anti-tumor(Jung et al., 2003) and vessels relaxation 
actions (Ko et al., 2003) were shown. 
In Chapter 2, the optimized 80% ethanol extract of Danshen-Yege has been 
determined. In order to elucidate the mechanism underlying its vasodilation 
and antioxidation effects, six pure compounds including the phenolic and 
isoflavonoid compounds from Danshen and Yege were investigated in the 
present study. The six pure compounds, including three from Danshen and 
three from Yege, namely salvianolic acid B, protocatechualdehyde, tanshinone 
IIA, and puerarin, daidzein and daidzin, were utilized to identify the active 
components for the Danshen-Gegen formula. Their concentrations in DY 80 
extract has been identified in the previous section and were shown in table 3.2. 
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Drugs Abbreviation Molecular Content % in 
Size DY 80 
Salvianolic acid B SAB 718 6.11% 
Protocatechualdehyde PC 138 0.44% 
Tanshinone IIA TIIA 294 0.4% 
Puerarin PUE 416 4.7% 
Daidzein DE 254 0.14% 
Daidzin DZ 416 1.08% 
Table 3.2 Content Percentages of Marker Compounds in DY 80. 
Abbreviations and molecular sizes were shown. 
3.2.2 Methods and Materials 
3.2.2.1 Source of Pure Compounds 
Protocatechualdehyde (3,4-dihydroxybenzaldehy de, 25g), puerarin 
(lOOmg), daidzein (25mg) were supplied by Sigma. Daidzin (5mg) was 
supplied by Fluka and tanshinone IIA was supplied by National Institute for the 
Control of Pharmaceutical and Biological Products (中國藥品與生物制品檢 
定所). 
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3.2.2.2 Purification and Identification of SAB 
Isolation of SAB 
Dried root of Danshen (1 Kilogram) was sliced and boiled with distilled 
water under reflux at lOO^C for 3 times, each for 2 hours and 2 liters of solvent. 
The decoction was cooled and filtered. The filtrate was then concentrated by 
rotor evaporator into 500ml solution. Absolute alcohol was added into the 
concentrated extract to make a final concentration of 70% ethanol mixture. 
Undissolved residue was precipitated and the mixture was filtered. The clear 
filtrate was then evaporated again to remove the ethanol and the residue was 
suspended by distilled water. The extract was then lyophilized into powder. 
A column (3.5cm x 45cm) with Macro-reticular resin DlOl was washed 
with distilled water. The extract powder was dissolved by water and 
chromatographed on the column. Water was applied to elute the inorganic salts 
and polysaccharides. Then, 50% ethanol was eluted to obtain the yellowish 
fraction which contains SAB. The fraction was further applied to liquid 
chromatography of a Sephadex LH-20 column. Successive increase of 
methanol percentage (20%, 40%, 60% and 70%) in water eluted four fractions 
DS-l(l.lg), DS-2 (200mg), DS-3 (260mg) and DS-4 (240mg). 
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Identification 
The collected fractions were subjected to Thin Layer Chromatography 
(TLC) and IH Nuclear Magnetic Resonance (NMR) for identification. For 
TLC, the silica gel TLC plate was used, with the mobile phase of Toluene: 
Ethyl acetate: Formic acid (4:4:1). Fraction DS-1 was identified as Salvianolic 
acid B, with a molecular size of 718. 
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3.2.2.3 Vasodilation model 
In purpose of identifying the active compound(s) in DY 80, for its 
vasodilative action, the same ex vivo assay, as described in Section 2.3.4, was 
used. The concentration of pure compounds administered into the organ bath 
was based on their content in DY 80 (table 3.3). 
Drugs Content % Concentration in Equivalence in Solvent 
in DY 80 Organ Bath (ng/ml) mM  
DY80 - 4000 - Krebs 
SAB 6.11% 245 0.34 Krebs 
PC 0.44% 18 0.13 Krebs 
0.3% 
TIIA 0.4% 16 0.054 
DMSO 
0.3% 
Puerarin 4.7% 188 0.45 
DMSO 
0.3% 
Daidzein 0.14% 5.6 0.023 
DMSO 
0.3% 
Daidzin 1.08% 43 0.104 
DMSO 
Table 3.3 Concentrations of pure compounds used in the vasodilation 
study ofDY 80. 
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3.2.2.4 Antioxidation Model 
Similarly, in order to investigate the active component(s) for the 
antioxidation action of DY 80, the same in vitro antioxidation assay, as 
mentioned in Section 2.3.3, was used in this study. Concentration of the pure 
compounds used was estimated according to their content in DY 80 (table 3.4). 
Successive two fold dilutions were performed to obtain the dose response. 
Drugs Content % Concentration of Equivalence in Solvent 
I 
in DY 80 the highest dosage mM 
(y^g/ml)  
DY80 - 1000 - PBS 
SAB 6.11% 61 0.085 PBS 
PC 0.44% 4.4 0.032 PBS 
2 5% 
TIIA 0.4% 4 0.014 ‘ 
DMSO 
2.5% 
Puerarin 4.7% 47 0.113 … … 
DMSO 
2.5% 
Daidzein 0.14% 1.44 0.006 
DMSO 
2.5% 
Daidzin 1.08% 10.8 0.026 
DMSO 
Table 3.4 Concentrations of pure compounds in the AAPH-induced 
RBC Hemolysis Study of DY 80. 
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3.2.2.5 Structures of Pure Compounds 
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3.2.3 Results 
3.2.3.1 Vasodilation Results 
Vasodilation responses of pure compounds, which were administered at 
concentration comparable to their contents in DY 80, were shown in figure 3.7. 
Among the pure compounds tested, only salvianolic acid B (SAB) and daidzein 
exerted very potent vasodilative effect. Vasodilating effect of daidzein was 
especially significant because of its very low concentration administered 
(5.6ug/ml, equivalent to 23uM) compared with that of SAB (245ug/ml, 
equivalent to 340uM). Both SAB and daidzein contributed to more than half of 
the vasodilatory effect of the crude extract DY 80. Puerarin, although showed a 
relaxation response of the vascular tone for 10%, this was not statistically 
significant compared to the control, i.e. without drug. 
Since the highest physiological active concentration of drugs used in 
western medicine for this aorta relaxation model is 0.1 mM, pure compounds 
showing no effect were further subjected to the test again at 0.1 mM. Among 
the pure compounds tested, only daidzein and Tanshinone IIA were at 
concentration lower than 0.1 mM. As daidzein was shown to have potent effect， 
only Tanshinone IIA was further tested at 0.1 mM (figure 3.8). However, no 
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vasodilation effect was observed even at this dosage, therefore it was regarded 
as a non-active compound. In conclusion, only SAB and daidzein were 
identified as active compounds for the vasodilative effect of the optimized 
Danshen-Gegen formula. 
广 1 * -t-SAB 
r . f ^ 
^ / J f 十 DY80 
30 • / ^ ^ * — Coaitol 
-10 i 10 20 30 40 5 0 60 70 80 
Time (min) n=6 
Fig. 3.7 Vasodilatory Effect of Pure Compounds on U46619-precontracted 
aorta rings. Results were expressed in percentages of relaxation of the 
precontracted tone in time-course experiment. The six pure compounds, 
salvianolic acid B (SAB), daidzein (DE), protocatechualdehyde (PC), puerarin 
(PUE), daidzin (DZ) and tanshinone IIA (TIIA), were tested with 
concentrations calculated in table 3.3. Data were shown as mean 土 SD (n=6). 
*P<0.001, SAB, DE & DY80 versus control.杜 P<0.001, DY80 versus SAB & 
DE. ^P<0.01 DY80 versus DE. Only SAB and DE showed significant 
vasodilatory effect. 
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Fig. 3.8 Vasodilation Study of Tanshinone IIA at 0.1 mM concentration. 
Results were expressed in percentage of relaxation of the precontracted tone in 
time-course experiment. Tanshinone IIA was applied to organ bath at maximum 
physiological active concentration of 0.1 mM. Data were shown as mean 土 SD 
(n=4). No vasodilatory response was shown compared to control 
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3.2.3.2 Antioxidation Results 
In order to identify the active compound(s) for the antioxidant effect of DY 
80, the six pure compounds were subjected to the antioxidation test, with 
concentrations comparable to their contents in DY 80 (table 3.4), and their 
effects were compared with that of DY 80 (figure 3.9). Among the six pure 
compounds tested, only Salvianolic acid B showed a potent effect on inhibition 
of hemolysis, with an IC50 of 40.2|j.g/ml (equivalent to 56|xM). Other five 
compounds did not show any effect at the tested concentrations. 
However, the antioxidant effect of SAB was found contributing to less than 
half of that produced by the crude extract DY 80 (figure 3.9), implying the 
possibility that other compounds present in DY 80 may account for the rest of 
the effect. Since the added concentrations of the pure compounds might be 
underestimated, compounds showing no effect were further studied at the 
highest concentration of ImM for the antioxidant effect. The results indicated 
that three other compounds exhibited antioxidant activities (figure 3.10). 
Among them, Protocatechualdehyde (90% Inhibition) showed the strongest 
antioxidant effect, followed by Puerarin (30% Inhibition) and Tanshinone IIA 
(20% Inhibition). 
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Fig. 3.9 Inhibitory Effect of Pure Compounds on AAPH-induced Red 
Blood Cell Hemolysis. Results were expressed in the percentage of inhibitory 
effect of the pure compounds on AAPH-induced red blood cells hemolysis. Pure 
compounds were tested according to their concentrations in DY 80 calculated 
in table 3.4 and their inhibitory effects were shown under the corresponding 
concentrations of DY 80. Concentrations showing in the graph represent that 
of DY80 and vitamin C only. Vitamin C was used as a positive control Data 
o 
were expressed as mean 土 SD (n=10). P<0.001, SAB versus other pure 
compounds. #P<0.001’ DY80 versus SAB. 
IC50 values of DY80, Salvianolic acid B and Vitamin C were 112, 40.2 and 
89.5fig/ml respectively. 
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Fig. 3.10 Inhibitory Effect of Pure Compounds at ImM on 
AAPH-induced Red Blood Cell Hemolysis. Results of pure compounds at the 
highest concentration of ImM were shown. Data were expressed as mean 土 SD 
(n=5). Protocatechualdehyde, tanshinone IIA and puerarin showed inhibitory 
effect on hemolysis at this concentration. IC 50 values of protocatechualdehyde 
and vitamin C were 96uM and 528uM respectively. 
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3.3 Discussion 
From the present study, salvianolic acid B (SAB) and daidzein were 
identified as the two major active compounds present in Danshen-Gegen 
formula. SAB is present in Danshen. It has long been identified to exhibit 
cardioprotective functions. Antioxidant or radical-scavenging effects have been 
extensively studied (Fung et al , 1993; Huang & Zhang, 1992; Wu et al., 1998). 
SAB possesses unsaturated rings with multiple phenolic hydroxyl groups in its 
structure, which is a common feature in antioxidants and may account for its 
antioxidant activity. On the other hand, the vasodilatory function of SAB was 
recently reported (Kamata et al., 1993). Our findings confirmed the same 
results, and identified this pure compound to be the active component of our 
formula. Besides inducing vasodilation, SAB is also beneficial to the 
prevention of other atherogenic events. These include its protective action 
against TNF-alpha injury in human aortic vascular endothelium cells by 
reducing cell adhesion molecules VCAM-1 and ICAM-1, which recruits 
leukocytes (Chen et al., 2001; Chen et al., 2001), improving blood circulations 
and renal functions (Yokozawa et al., 1991), antifibrotic activity (Shigematsu et 
al., 1994), reducing myocardial damage in an ischemia-reperfusion model 
(Fung et al., 1993), inducing apoptosis in neointima, which help prevent the 
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neointimal thickening (Hung et al” 2001), inhibiting VEGF-induced 
hyperpermeability (Qui et al., 2001) and antihypertensive effect which may be 
related to ACE inhibitory property (Kang et al., 2003). 
Regarding daidzein, previous studies have been focused on its beneficial 
effects on postmenopausal women as an estrogen-analog supplement. Yet, only 
a few studies have reported its vessel relaxant effects (Mishra et al., 2000; 
Karamsetty et al., 2004). Daidzein belongs to a group of compounds called 
isoflavones; the latter form a part of the group phytoestrogens. Phytoestrogens 
are polyphenolic non-steroidal plant compounds which have biological 
activities similar to estrogen 17beta-estradiol (Murkies et al., 1998) and may 
exhibit selective estrogen receptor modulating activities due to their similar 
structures. Studies showed that high consumption of phytoestrogen has 
protective effects on cardiovascular diseases (Bakhit et al., 1994; Teede et al., 
2001) and lowers the total and LDL-cholesterol level (Grouse et al., 1999; 
Gardner et al., 2001), also exhibits beneficial effects in osteoporosis (Potter et 
al., 1998) and cancers (Lee et al” 1991). Among the groups of phytoestrogens, 
isoflavones is the most studied one. Daidzein and puerarin from Gegen belong 
to this group. Isoflavones has been reported to reduce plasma cholesterol, 
probably by up-regulating LDL-receptors, and hence reducing atherosclerosis 
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(Kirk et al., 1998). Antioxidant activity of isoflavones has also been reported 
(Rufer & Kulling, 2006). However, in this study, no antioxidant activity of 
daidzein has been shown. 
Daidzein may act like estrogen, and thereby prevent atherosclerosis. 
Previous study has demonstrated that Yege has estrogenic activities (Zhang et 
al., 2005). The action of estrogen has been extensively studied. It was known to 
decrease the risk of coronary disease in postmenopausal women (Nabulsi et al.， 
1993), increase HDL cholesterol and decrease LDL cholesterol in vivo (Walsh 
et al., 1991), inhibit SMC proliferation and migration (Suzuki et al., 1996), 
increase NO production and eNOS protein expression (Hayashi et al., 1995). 
Direct action of estrogen on vessel walls has been reported, and estrogen 
receptors were found in the vascular endothelium and smooth muscle cells. It is 
possible that daidzein may act on these estrogen receptors to exert its function. 
Besides, it has been reported that the majority of daidzein present in plant is in 
the form of inactive glycoside Daidzin and derivative biochanin A. It was 
reported that these precursors can be metabolized in the digestive tract by 
enzymes into the active form daidzein (Day et al., 1998). If this is the case, the 
beneficial effect of this formula might be enhanced by a higher content of 
Daidzin detected in the extract, which may be converted into the active form 
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daidzein in vivo. Other cardioprotective functions of daidzein reported include 
the reduction in monocyte chemoattractant protein-1 (MCP-1) secretion 
induced by TNF-a in human umbilical vein endothelial cells (Gottstein et al., 
2003) and anti-thrombotic effects (Choo et al., 2002). 
Besides SAB and daidzein, previous research reported that the activity of 
other pure compounds present either in Danshen or Yege may be beneficial in 
inhibiting atherogenesis. For pure compounds of Danshen, rosmaric acid were 
found to lower the production of superoxide anion radical (O2 •) in the xanthine 
oxidase system, showing anti-thrombotic and antiplatelet effects (Zou et a l . , 
1993). Tanshinones were found to inhibit platelet aggregation, protect 
myocardium against ischemia-induced derangements (Lin et al., 2001; Yagi et 
al., 1989) and inhibit inflammatory responses (Kim et al., 2002). 
Protocatechualdehyde was found to selectively inhibit cytokine-induced 
VCAM-1 and ICAM-1 expression and reduce monocyte adhesion to 
endothelium cells through actions involving NF-K B and AP-1 (Zhou et al., 
2005). Other polyphenolic compounds were reported to exert antioxidant, 
anti-ischemic reperfusion, anti-thrombosis, anti-hypertension and anti-fibrosis 
actions(Jiang et al., 2005a). In contrast, less research has been done on active 
compounds in Yege compared with those in Danshen. Yet, some major 
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compounds have been identified. Genistein was found to reduce plasma 
homocysteine level, prevent oxidation (Chen et al., 2005) and inhibit the 
occlusion of thrombotic vessel (Kondo et al., 2002). Puerarin decreases serum 
total cholesterol (Yan et al., 2006b), inhibits arrhythmias (Chai et al., 1985), 
suppresses proliferation of vascular smooth muscle cells (Xu et al., 2006) and 
induces endothelium-independent relaxation (Dong et al., 2004). However, our 
study did not show any vasodilating property of puerarin, although it is the 
most abundant isoflavones in Gegen. 
After identifying SAB as a potent vasodilator and antioxidant, and daidzein 
as a potent vasodilator, the results of previous studies could be further 
elucidated here. As elaborated in the previous chapter, increasing the ethanol 
percentage in the extraction process up to 80% enhanced the vasodilative and 
antioxidative activities, but antioxidant effect of the extract markedly reduced 
when 90% ethanol was used. HPLC analysis indicated that highly non-polar 
solvent (90% ethanol) failed to dissolve and extract polar compounds, 
protocatechualdehyde and SAB, and hence resulted in a drop in the contents of 
these water-soluble substances in the extract. Since SAB and 
protocatechualdehyde were identified as the two major pure compounds 
account for the antioxidant activity of DY extract, the drop in their content may 
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explain the reduction in antioxidant effect of DY 90. Although SAB content in 
DY 90 was reduced, the increase in daidzein content, another more potent 
vasodilator, may help compensate for the loss and resulted in an overall greater 
vasodilation effect of DY 90 than other extracts. However, among the extracts, 
DY 80 had the most holistic and balanced amount of active compounds in 
proportion and in optimal contents, thus possessing potent effects in both 
antioxidant and vasodilatory activities. 
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3.4 Synergistic Effect Study 
3.4.1 Introduction 
As mentioned previously, different compounds in an herbal extract may 
work together to enhance activities. Since two pure compounds have been 
identified, one (SAB) present in Danshen and one (daidzein) present in Gegen, 
both of which contribute to much of the vasodilating effect demonstrable in the 
crude extract (DY 80), a question arises if these two compounds could produce 
synergistic effect on antioxidation and vasodilation. 
3.4.2 Methods 
The same vasodilation assay model, as described in Chapter 2, was used. 
The concentrations of SAB and daidzein used were the same as in the previous 
section, i.e. 245 and 5.6 |i/ml, respectively. The two pure compounds were 
combined before administering to the precontracted aorta rings suspended in 
organ baths. 
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3.4.3 Results 
SAB and daidzein were examined for synergistic effect on the vasodilation 
action. The combination of SAB and daidzein resulted in a significantly higher 
vasodilative effect as compared with that of the individual active compound 
(figure 3.11). However, the effect of this combination did not outperform the 
effect of the summation of SAB and daidzein. And the effect of this 
combination of SAB and daidzein could not completely account for the effect 
of DY 80, as a significant difference in response was shown at 10 minutes after 
the administration of drugs. 
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Fig. 3.11 Synergistic Study of Salvianolic acid B and Daidzein on 
Vasodilation Effect. Results were expressed in percentages of relaxation of the 
precontracted tone in a time course experiment. SAB and daidzein were 
combined just before adding into the precontracted aortic rings. Data was 
shown in mean 土 SD (n=7). $P<0.01’ SAB+DE versus SAB & DE. 
&P<0M5，SAB+DE versus DE. * P<0.05, DY 80 versus SAB+DE The 
maximum difference in the relaxation response between the combination of 
SAB and daidzein with SAB and daidzein alone were 37.13 土 5.7% and 40.9 土 
3.27 respectively. 
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3.4.4 Discussion 
Combination of SAB and daidzein was shown to exert an additive effect, 
which means the outcoming response was approximately equal to that of the 
summation of the individuals. The additive action was shown to be close to that 
of the crude extract, and hence SAB and daidzein were likely to contribute 
mainly to the vasodilatory activity of DY 80. The possible presence of other 
active compounds in DY 80 may explain the rest of the vasodilative effect 
detectable in DY 80. 
The present study did not show synergistic effect between SAB and 
daidzein. This may be due to the fact that the two active compounds were 
combined shortly just before adminstered to the aortic rings, the time might be 
insufficient for the compounds to interact and enhance each other's activity. 
Longer time and heating may be needed to micmic the boiling effect during 
extraction process and let the compounds to interact to generate possible 
synergistic effect. Synergistic interactions of pure compounds are of vital 
importance in herbal medicines, which may also provide an explanation for the 
efficacy of apparently low doses of active constituents in an herbal extract. 
Synergistic interactions among different constituents within a single herb, as 
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well as between different herbs in a formulation were documented (Williamson, 
2001). It is possible, but not shown in our results that the presence of one 
compound may somehow enhance the drug bioavailability and biological 
action of the other, so as to exaggerate the vasodilation effect. The findings in 
the present study demonstrated an additive but not synergistic effect between 
the compounds from two different herbs, which provides evidence that the 
compound formula of Danshen and Gegen can outperform the single herb. And 
this result implied that the pure compounds, SAB and daidzein, may act 
through different mechanisms to induce vasodilation. The mechanisms 
underlying the pharmaceutical actions of these two compounds were studied, 
as described in later chapters. 
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3.5 Study on 3'-hydroxypuerarin and 3'-methoxypuerarin purified 
from Yege 
3.5.1 3，-hydroxypuerarin and 3'-methoxypuerarin 
Apart from the more commonly studied pure compounds investigated in 
previous section, 3,-hydroxypuerarin and 3‘-methoxypuerarin are two other 
pure compounds which have been identified in Yege, but absent in Fenge 
(Jiang et al., 2005b). These two pure compounds may contribute to the 
difference in the bioactivity reported between these two types of Gegen. But so 
far no previous studies have reported the cardiotonic effect of these two pure 
compounds. Therefore, we propose to purify and study these two compounds 
in the herbal formula extract. 
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Fig. 3.12 Structures of 3'-hydroxypuerarin and 3，-methoxypuerarin. The 
two compounds are derivatives of puerarin. They are similar in structures, with 
a difference at C3, as 3 '-hydroxypuerarin possess a hydroxyl group while 
3 '-methoxypuerarin possess a methoxyl group at this position. 
3.5.2 Methods and Materials 
3.5.2.1 Purification by HPLC semi-preparation 
Isolation 
3'-hydroxypuerarin and 3'-methoxypuerarin were purified by 
semi-preparative HPLC. Dried root of Yege (50g) was sliced and extracted 
with distilled water at room temperature in ultrasonic water bath for one hour, 
two times. The extracted solutions were pooled together and concentrated by 
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rotor evaporation under reduced pressure to yield dried powder (5.1g). The 
extract of Yege was then dissolved in 15% Acetonitrite (ACN) to give a 
1 OOmg/ml solution. The solutions were filtered through a 0.45jim filter before 
transferring to autosampler vials ready for HPLC purification. The 
semi-preparative HPLC of Yege extracts was performed in the Beckman 
Ultrasphere ODS, 5u, 10mm x 250mm column, with detection by Beckman 
System Gold 508/125/168. Using a mobile phase of 85% A: 0.2% acetic acid 
and 15%B: ACN. The flow rate was maintained as Iml/min and detection 
wavelength was set at 254nm. Fractions containing the two pure compounds 
were collected respectively. The solvent was then evaporated and the pure 
compound powders were obtained by lyophilization. 
Identification 
The yield of 3'-hydroxypuerarin and 3‘-methoxypuerarin were 5.8mg and 
4.9mg respectively. These two pure compounds purified were identified as 
3，-hydroxypuerarin and 3,-methoxypuerarin by 1H-NMR and ESI-MS. 
Molecular size of 3'-hydroxypuerarin and 3 '-methoxypuerarin are 432 and 446, 
respectively. 
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3.5.2.2 Bioassays 
The same protocols for vasodilative and antioxidant properties, as 
described in Chapter 2, were used in the present study. The concentrations of 
3 ‘-hydroxypuerarin and 3 ‘ -methoxypuerarin were administered at their 
maximum physiological active of 0.1 mM into organ baths, respectively, for the 
vasodilative function test. In advance of investigating the antioxidative 
activities of 3'-hydroxypuerarin and 3‘-methoxypuerarin, the antioxidant effect 
of 80% ethanol extract of Yege was first verified. The 80% ethanol extract of 
Yege was prepared by the same extraction method, as described in chapter 2, 
and subjected to antioxidation assay at the highest concentration of 2mg/ml. 
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3.5.3 Results 
3.5.3.1 Vasodilation Study 
Purified 3‘-hydroxypuerarin and 3‘-methoxypuerarin were subjected to the 
vasodilation assay. However, when compared with the control (0.025% DMSO) 
without drug, both 3 ‘ -hydroxypuerarin and 3 ‘ -methoxypuerarin did not show 
any significant vasodilating activity. 
100 
80 -
“•~3'-hydroxypuerarin g _ 
60 • '-methox3T)uerariii 
S Control 
(L>  
a： 40 . 
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Fig. 3.13 Vasodilative Study of 3'-hydroxypuerarin and 
3'-methoxypuerarin on U46619-precoiitracted rat aorta rings. Maximum 
physiological active concentration of O.lmM of 3 '-hydroxypuerarin and 
3 '-methoxypuerarin were administrated to aortic rings respectively. Data were 
expressed as 土 SD (n=5). No vasodilative effect was shown. 
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3.5.3.2 Antioxidative Effect of Yege 
80% ethanol extract was prepared and subjected to the antioxidation assay. 
The extract at different concentrations was studied to obtain the response curve. 
The results showed that this extract exerted a maximum inhibitory effect of 
approximately 50% inhibition on cell hemolysis at 1 mg/ml concentration. 
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Fig. 3.14 Inhibitory Effect of 80% ethanol extract of Yege on 
AAPH-induced RBC Hemolysis. The results were expressed as the 
percentage of inhibitory effect on AAPH-induced red blood cells hemolysis. 
Data were expressed as mean 土 SD (n=4). Maximum inhibitory effect was 
shown at 1 mg/ml for 47.7 ±8.5 o/o. 
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3.5.4 Discussion 
Since 3 ‘ -hydroxypuerarin and 3 ‘ -methoxypuerarin are present in Yege, but 
not in Fenge (Jiang et al., 2005b). These two pure compounds may somehow 
contribute to the pharmacological difference between the two species of Gegen. 
The two compounds purified were first subjected to vasodilative functional 
study. However, no vasodilating effect was shown. Therefore, these two 
compounds are not likely to account for the more potent vasodilative effect of 
Yege compared with that of Fenge. The greater vasodilative response induced 
by Yege may solely be contributed by the higher content of daidzein, the active 
vasodilator, present in Yege (0.14%) compared with that present in Fenge 
(0.05%) (Jiang et al., 2005b). 
These two pure compounds may, however, contribute to the antioxidation 
property of Yege. Previous study by my colleague (Yam, 2005) has shown no 
antioxidant activity of Fenge. However, in the present study, the ethanol extract 
of Yege has showed an inhibitory effect on free radical-induced hemolysis, 
inferring that besides puerarin (40% inhibition at ImM), other compounds may 
contribute to the overall antioxidant effect of Yege. Therefore, it was proposed 
that 3 ‘-hydroxypuerarin and 3，-methoxypuerarin may exhibit some extent of 
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antioxidant effect. However, the putative antioxidative property of 
3'-hydroxypuerarin and 3‘-methoxypuerarin remains to be determined, owning 
to the insufficient amount of pure compounds prepared. A further study would 
be needed after the purification of a larger amount of these two compounds. 
- 9 7 - . 
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Blood vessels are composed of smooth muscle cells and an inner 
monolayer of endothelial cells, which are crucial in regulating vascular tone. 
Upon stimulation, constricting or dilating messagers are released from the 
endothelial cells, acting on the smooth muscle (SMC) cells through different 
pathways and eventually causing SMC to contract or relax, changing the 
diameter and blood flow in vessels. The mechanism of actions of DY 80 and 
the two active compounds, SAB and daidzein, on inducing vasodilation was 
studied in the present study. 
Vasoconstriction 
Endothelial cells are capable to release vasoconstricting substances, 
including prostanoids such as thromboxane A2 and prostaglandin H2, 
endothelin, vasopressin and superoxide anions. All these substances cause an 
increase in intracellular calcium level [Ca ]i and cause contraction of the 
smooth muscle. 
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Vasodilation 
Three endogenous vasodilators released by the endothelium include 
endothelium derived relaxing factor (EDRF/NO), prostacyclin (PGI2) and 
endothelium-derived hyperpolarizing factor (EDHF), all subsequently act on 
the smooth muscle and result in the relaxation. 
4.1.1 Nitric Oxide-mediated Vasodilation 
Endothelium derived relaxing factor (EDRF), is commonly known as nitric 
oxide (NO), includes also its closely related nitroso-containing compounds. 
Substances which cause vasodilation through this pathway increase the 
production of NO in endothelial cells. Enhanced NO production is mediated by 
the activation of nitric oxide synthase (NOS) which convert the substrate 
L-arginine into NO. Once released from the endothelium, NO diffuses through 
the vascular wall into the smooth muscle cell and activates the cytosolic 
enzyme guanylate cyclase (GC) to increase cyclic GMP (cGMP) level. This 
increase in cGMP activates the protein kinase G (PKG), inhibits calcium entry 
into the SMC, activates K+ channels, and decreases IP3, causing relaxation of 
the smooth muscle cells. There are three isoforms of the enzyme NOS, namely 
endothelial constitutive NOS (eNOS), inducible NOS (iNOS) and neuronal 
- 9 9 -
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NOS (cNOS). eNOS is the most important form of NOS in the cardiovascular 
system. It is the main enzyme responsible for the continual production and 
release of NO by the endothelium cells. Many vasodilators were demonstrated 
to act through this pathway (Furchgott, 1984; De Mey & Vanhoutte，1981) 
4.1.2 Prostacyclin-mediated Vasodilation 
Prostacyclin (PGI2) is produced in endothelial cells from prostaglandin H2 
by the action of enzyme prostacyclin synthase. Its action counteracts that of 
thromboxane, a vasoconstrictor. After releasing from the endothelium, it 
promotes vasodilation by increasing the cellular cyclic AMP in smooth muscle 
cells, which in turn activates protein kinase A (PKA). PKA inhibits Ca influx 
into smooth muscle, lowering and thus cause muscle relaxation. Besides 
vasodilation, the most important role of PGI2 is limiting platelet attachment and 
aggregation. 
- 1 0 0 - . 
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4.1.3 EDHF-mediated Vasodilation 
Endothelium-derived hyperpolarizing factor (EDHF) is defined as the 
non-nitric oxide (NO) and non-prostacyclin (PGI2) substance that mediates 
hyperpolarization of vascular smooth muscle cells and cause relaxation. The 
chemical nature of EDHF is unknown. However, these factors contribute to 
vasodilation by opening the K+ channels on SMC, causing hyperpolarization 
via regulating the calcium gradient and extracellular calcium, resulting in 
relaxation of smooth muscle. Several types of K+ channels are expressed on 
smooth muscle cells, namely Kir, BKca, Kv, etc. 
Inwardly rectifying K+ channels (Kir) 
Inwardly rectifying K+ channels (Kir) is one of the most important channels 
for the control of the resting potential of cells. These channels are characterized 
by its ability to allow large inward currents and smaller outward currents. Kir is 
a K+ sensor, even a small increase in the extracellular K+, would increase the 
conductance of Kir. 
- 1 0 1 -
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2+ + High-conductance Ca -activated K channels (BKca) 
High-conductance Ca^^-activated K+ channels (BKca) respond rapidly to 
both increase in intracellular calcium level and voltage, which enhance its 
opening. Isoforms of this channel include intermediate-conductance channel 
(IKca) and small-conductance channel (SKca). 
Voltage-dependent K+ channels (Kv) 
Voltage-dependent K+ channels (Kv) are mainly located on smooth muscle 
cells. It is also regarded as delayed rectifying IC+ channel and responds to 
voltage changes. 
- 1 0 2 -
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4.1.4 Endothelium-dependent and -independent Vasodilations 
As mentioned previously, endothelium is vital in vascular functions which 
include controlling coagulation, fibrinolysis, vascular tone and growth. Any 
substance which may restore or increase bioavailability of endothelial products, 
such as NO, prostacyclin and EDHF, raises the possibility of modifying arterial 
function and may reverse endothelial dysfunction conditions. Studies have 
reported the possibility of certain strategies to reverse endothelial dysfunction 
(Levine et al., 1996; Clarkson et al., 1996). Actions of these potential 
substances have to be on the endothelium, inducing the release of powerful 
vasodilators as a consequence and in turn improve the health of the 
endothelium. • 
Therefore, endothelium-dependent or -independent vasodilation was 
determined in the present study by using specific ligands to block enzymes or 
mediators located on endothelium or smooth muscle cells of vessels. Changes 
due to removal of endothelium was also studied, which may cause an 
attenuation of effect induced by that drugs. Drugs targeting on the endothelium 
for its actions may be more relevant in the prevention of atherogenesis, for 
their possibility to improve the endothelium and hence the vascular health. 
- 1 0 3 -
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4.2 Methods and Materials 
The same assay for studying the vasodilation function, as mentioned in 
Chapter 2, was used in the present study, to investigate the change in vascular 
relaxation tone by different inhibitions. Animals, aorta isolation and 
preparation procedures were performed as described previously. 
Denuded aorta rings preparation 
Aorta rings (2mm) were subjected to mechanical removal of endothelium 
by rubbing the aorta lumen with a steel wire. After equilibration and gradually 
stretched the rings to 1.5g resting tension, 0.3uM of Phe was used to test the 
normal functioning of smooth muscle layer, followed by Ach. Complete 
removal of endothelium gave no relaxation in response to Ach. The aorta rings 
were then washed with warmed Krebs solution to restore tension back to their 
resting value. The rings were equilibrated again for an hour before 
precontraction by U46619 and addition of corresponding drugs. 
- 1 0 4 -
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High K+ solution treatment 
KCl (60mM)-containing solution was prepared by substituting NaCl in 
Krebs solution by an equal molar of KCl to retain constant ionic strength. After 
testing endothelium integrity and equilibration, aorta rings were suspended in 
high K+ solution by replacing 8ml 60mM KCl Krebs solution into organ baths. 
Aortic contraction was induced, corresponding drugs were added after the 
appearance of sustained tone. 
Blockers treatment 
After testing endothelium integrity and equilibration, specific blockers 
were added into organ baths, with aorta rings suspended for 30 minutes. Then, 
either lOmM or 15mM U46619 was added to obtain an initial contracted tone 
similar to that without blockers. Corresponding drugs were then added after the 
sustained contracted tension. The following table presented the action, 
concentration and source of different blockers (table 4.1). 
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Blockers Full Name Action Concentration Source U46619 
NG-nitro-L-argini Non-specific nitric … �， . 
L-NAME . . . 100//M Sigma 15mM 
ne methyl ester oxide synthase inhibitor 
lH-[l,2,4]oxadia 
zolo- Guanylate cyclase � " . 




Indomethacin - , 1 " M Sigma lOmM 
cycioxgenase 
BaCl2 Barium chloride Kir channel blocker 0.3mM Merck 15mM 
Tetraethylammon Non-selective BKca 
TEA lOmM Sigma 15mM 
ium chloride channel blocker 
4-AP 4-aminopyridine Kv channel blocker 3mM Sigma 15mM 
Table 4.1 Inhibitors used for mechanism study, showing full names, 
concentration, source and actions. 
w Vasodilator (e.g. 
• ACh, Bradykinin) 
[ 〒 ] 个 w ^ ^ 
V | L - N A M E | ^ I EDHF POK ) 
eN�S Cell 
3 Na+ \ 
^ �V ^  
A T P ^ Smooth 
^ Z 6TP Muscle Cell 
\ Relaxation J 
K, ^s. I K+  
� ’ �4 - A P 
Fig. 4.1 Vasodilation mechanisms and Blockers Effect. Red arrows 
represent the action of blockers and blue arrows represent activations. 
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4.3 Results 
After the identification of active compounds responsible for DY 80 
extract's vasodilating response in the previous section, in the present study, the 
mechanism underlying the actions of these pure compounds (SAB and daidzein) 
and the crude extract (DY 80) were investigated. 
4.3.1 Danshen-Gegen Formula (DY 80) 
According to the results shown in figure 4.2 — 4.5, relaxation tone induced 
by DY 80 extract remained unchanged in denuded aorta rings and in rings 
treated with L-NAME, ODQ and indomethacin. However, in the presence of 
elevated extracellular K+, the relaxation response of DY 80 was partially 
abolished (figure 4.6). Further investigation showed that aortic rings treated 
with BaCb, TEA and 4-aminopyridine, demonstrated a certain degree of 
inhibition of the DY 80-induced relaxation tone (figure 4.7 - 4.9). 
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DY 80 
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Fig. 4.2 Effect of denuded aorta rings on DY 80-induce relaxation 
compared with intact rings. Percentage of relaxation of the pre-contracted 
tone was compared in the course of time. ‘‘+ endo “ represents the effect of 
DY80 on intact aorta rings, “-endo “ represents the effect of DY80 on denuded 
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Fig. 4.3 Effect of L-NAME on DY 80-induced relaxation of intact aorta 
rings. L-NAME (100//M) was added 30 minutes prior to the addition of DY 80 
(4mg/ml). Data were presented as mean ±SD (n= 5). No inhibitory effect was 
shown. 
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DY80 
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Fig. 4.4 Effect of ODQ on DY 80-induced relaxation of intact aorta rings. 
ODQ (S //M) was added 30 minutes prior to the addition of DY 80 (4mg/ml). 
Data were presented as mean ±SD (n= 6). No inhibitory effect was shown. 
DY80 
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Fig. 4.5 Effect of Indomethacin on DY 80-induced relaxation of intact 
aorta rings. Indomethacin (IjuM) M'as added 30 minutes prior to the addition 
of DY80 (4mg/ml). Data were presented as mean 土 SD (n= 6). No inhibitory 
effect was shown. 
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DY80 
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Fig. 4.6 Effect of High extracellular K+ on DY 80-induced relaxation of 
intact aorta rings. Precontraction was induced by U46619 and 60mM KCl 
krebs solution respectively before the addition of DY 80 (4mg/ml). Data were 
presented as mean ±SD (n= 5). * P<0.05, ** P<0.01,枯 P<0.001, DY80 (U4) 
versus DY80 (High iC). The maximum inhibition was 土 1.06%. 
DY 80 
fr^ ^ ^ 
I 40 - I 一 DY80 
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Fig. 4.7 Effect of Barium Chloride on DY 80-induced relaxation of intact 
aorta rings. Barium Chloride (O.SmM) was added 30 minutes prior to the 
addition of DY 80 (4mg/ml). Data were presented as mean 土 SD 5), 
** P<0.01. The maximum inhibition was 29.52 土 
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DY80 
t-ff ^ ^ ^ 
承 i A -o-TEA+DYBO 
10 V . . . 
pC： 1 1 1 1 
i 20 40 60 GO 
Tmie {nnin) 
Fig. 4.8 Effect of TEA on DY 80-induced relaxation of intact aorta rings. 
TEA (lOmM) was added 30 minutes prior to the addition of DY 80 (4mg/ml). 
Data were presented as mean 土 SD (n= 5), ** P<0.01, “ P<0.001. The 
maximum inhibition was 44.37 ± 6.71%. 
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Fig. 4.9 Effect of 4-aminopyridine on DY 80-induced relaxation of intact 
aorta rings. 4-aminopyridine (3mM) was added 30 minutes prior to the 
addition of DY80 (4mg/ml). Data were presented as mean 土 SD 5), * 
P<0.05. The maximum inhibition was 22.57 ± 8.05%. 
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4.3.2 Salvianolic acid B 
In figure 4.10 - 4.13, SAB showed no change in the relaxation response of 
aorta rings after the removal of endothelium and treatment with indomethacin. 
However, when rings were treated with L-NAME or ODQ, the relaxation 
response was partially but significantly inhibited. In figure 4.14, in the 
presence of high extracellular K+, SAB-induced relaxation was completely 
abolished. Figure 4.15 - 4.17 showed that the treatment with BaCh and TEA 
significantly inhibited the relaxation response of SAB and 4-aminopyridine 
could partially inhibit the effect. 
110 r 以 B 
！:： 
^ ^ — + endo 
承 30 - T ^ ^ — - endo 
10 ^ 
1 1 1 1 
•ID i 20 40 60 80 
Time (min) 
Fig. 4.10 Effect of denuded aorta rings on SAB-induce relaxation 
compared with intact rings. Percentage of relaxation of the pre-contracted 
tone was compared in the course of time. “+ endo ” represented the effect of 
SAB on intact aorta rings, “-endo “ represented the effect on denuded rings. 
Data were presented as mean 土 SD (n= 5). No inhibitory effect was shown. 
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Fig. 4.11 Effect of L-NAME on SAB-induced relaxation of intact aorta 
rings. L-NAME (100 //M) was added 30 minutes prior to the addition of SAB 
(0.245mg/ml). Data were presented as mean ±SD (n= 5)，*P<0.05, ** P<0.01. 
The maximum inhibition was 28.47 土 1.12o/o. 
SAB 
I : : 
^ 50 - T / / 
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Fig. 4.12 Effect of ODQ on SAB-induced relaxation of intact aorta rings. 
ODQ (3 //M) was added 30 minutes prior to the addition of SAB (0.245mg/ml). 
Data were presented as mean 土 SD (n= 5), *P<0.05, ** P<O.OL The 
maximum inhibition was 40.43 土 1.86%. 
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Fig. 4.13 Effect of Indomethacin on SAB-induced relaxation of intact 
aorta rings. Indomethacin (1 juM) was added 30 minutes prior to the addition 
of SAB (0.245mg/ml). Data were presented as mean ± SD (n= 5). No inhibitory 
effect was shown. 
SAB 
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I 80 • 
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Fig. 4.14 Effect of High extracellular K+ on SAB-induced relaxation of 
intact aorta rings. Precontraction was induced by U46619 and 60mM KCl 
Krebs solution respectively before the addition of SAB (0.245mg/ml). Data 
were presented as mean 土 SD (n二 4). ** P<0.01, ^ P<0.001, SAB (U4) versus 
SAB (High iC). The maximum inhibition was 95.61 + 5.21%. 
- 1 1 4 -
Chapter 4 Mechanistic Study 
SAB 
I:: 
^ 40 • y 丄 
承 X 林 j r - ^ S A B 
0 20 40 60 80 
Time (min) 
Fig. 4.15 Effect of Barium Chloride on SAB-induced relaxation of intact 
aorta rings. Barium Chloride (0.3mM) was added 30 minutes prior to the 
addition of SAB (0.245mg/ml). Data were presented as mean 土 SD (n= 5), 
** P<0.01,杜P<0.001. The maximum inhibition was 55.79 土 4.83o/o. 
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Fig. 4.16 Effect of TEA on SAB-induced relaxation of intact aorta rings. 
TEA (lOmM) was added 30 minutes prior to the addition of SAB (0.245mg/ml). 
Data were presented as mean±SD (n= 5)，*P<0.05, ** P<0.01, ^ P<0.001. 
The maximum inhibition was 54.7 土 2 05%. 
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Fig. 4.17 Effect of 4-aminopyrdine on SAB-induced relaxation of intact 
aorta rings. 4-aminopyridine (3mM) was added 30 minutes prior to the 
addition of SAB (0.245mg/ml). Data were presented as mean 土 SD (n= 5), 
* P<0.05. The maximum inhibition was 25.64 + 10.08%. 
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4.3.3 Daidzein 
As shown in figure 4.18 - 4.21, the removal of endothelium layer and 
treatment with L-NAME, ODQ or indomethacin can significantly and 
effectively cause the attenuation of the relaxation response induced by daidzein. 
In figure 4.22, treatment with high extracellular K+ completely abolished the 
daidzein-induced relaxation. Further examination showed that BaCb, TEA and 
4-aminopyridine can cause almost complete abolition of the response induced 
by daidzein (figure 4.23 - 4.25). 
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Fig. 4.18 Effect of denuded aorta rings on Daidzein-induce relaxation 
compared with intact rings. Percentage of relaxation of the pre-contracted 
tone was compared in time course experiment. "+ endo ” represents the effect 
of daidzein on intact aorta rings, “-endo “ represents the effect of daidzein on 
denuded rings. Data were presented as mean ±SD (n= 6). The maximum 
inhibition was 68.16+ 12.03%. 
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Fig. 4.19 Effect of L-NAME on Daidzein-induced relaxation of intact 
aorta rings. L-NAME (100 //M) was added 30 minutes prior to the addition of 
daidzein (0.0056mg/ml). Data were presented as mean 土 SD 6),社 P<0.001. 
The maximum inhibition was 80.54 土 1.58%. 
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Fig. 4.20 Effect of ODQ on Daidzein-induced relaxation of intact aorta 
rings. ODQ (3 was added 30 minutes prior to the addition of daidzein 
(0.0056mg/ml). Data were presented as mean ±SD (rv= 6),社 P<0.001. The 
maximum inhibition was 79.41 土 5.89%. 
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Fig. 4.21 Effect of Indomethacin on Daidzein-induced relaxation of intact 
aorta rings. Indomethacin (1 juM) was added 30 minutes prior to the addition 
of daidzein (0.0056mg/ml). Data were presented as mean 土 SD (n= 6), 
** P<0.01,括 P<O.OOL The maximum inhibition was 67.33 土 3.24o/o. 
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Fig. 4.22 Effect of High extracellular K+ on Daidzein-induced relaxation 
of intact aorta rings. Precontraction was induced hy U46619 and 60mM KCl 
Krebs solution respectively before the addition of daidzein (0.0056mg/ml). 
Data were presented as mean 土 SD (n= 5). ** P<0.01,枯 P<0.001, DE (U4) 
versus DE (High fC). The maximum inhibition was 87.39 + 2.83%. 
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Fig. 4.23 Effect of Barium Chloride on Daidzein-induced relaxation of 
intact aorta rings. Barium Chloride (O.SmM) was added 30 minutes prior to 
the addition of daidzein (0.0056mg/ml). Data were presented as mean 土 SD 
(n= 4), **P<0.01, # P<0.001. The maximum inhibition was 87.54 土 237%. 
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Fig. 4.24 Effect of TEA on Daidzein-induced relaxation of intact aorta 
rings. TEA (lOmM) was added 30 minutes prior to the addition of daidzein 
(0.0056mg/ml). Data were presented as mean 土 SD (n^ 5), **P<0.01, 
# P<O.OOL The maximum inhibition was 90.8 土 0.94o/o. 
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Fig. 4.25 Effect of 4-aminopyridine on Daidzein-induced relaxation of 
intact aorta rings. 4-aminopyridine (3mM) was added 30 minutes prior to the 
addition of daidzein (0.0056mg/ml). Data were presented as mean 土 SD (n= 5), 
**P<0.01, # P<0.001. The maximum inhibition was 82.12 土 7. lAVo. 
4.4 Discussion 
In order to define the mechanism involved in the vasodilation response 
afforded by DY 80 extract and its active ingredients, the change in the 
relaxation profile were compared between aorta rings with intact endothelium 
and aorta rings with denuded endothelium, and the effects of specific blockers 
were examined. Should removal of endothelium abolish the relaxation effect of 
the drug, the drug may mediate an endothelium-dependent relaxation. 
Otherwise, an endothelium-independent relaxation could be inferred. L-NAME 
inhibits the enzyme nitric oxide synthase (NOS) which synthesizes nitric oxide 
(NO) in the endothelium. Released NO will activate the guanylate cyclase (GC) 
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in smooth muscle cell to initiate the relaxation, with the latter being inhibited 
by ODQ. Experiments using the two blockers aimed to examine whether the 
drug acts through the NO-mediated relaxation pathway. Besides, indomethacin 
inhibits the enzyme cyclooxygenase (COX), which synthesizes prostaglandin 
H2, the precursor of prostacyclin. This study aimed to examine whether the 
drug acts through the prostacyclin pathway. High extracellular K+ generates 
vascular contraction response, if relaxation induced by a specific drug was 
abolished in reduced electrochemical gradient of K+, the drug may act through 
the opening of potassium channels. BaCb specifically blocks Kir channel, TEA 
is specific to BKca while 4-AP blocks the voltage-dependent Kv channel. 
Specific blockage of K+ channel can define which channel is involved in the 
drug-induced relaxation response. 
As illustrated in the earlier chapter, SAB and daidzein were the two major 
active compounds which contributed to the vasodilation activity of DY 80 
extract. Results showed that action of SAB was either via the NO-dependent or 
EDHF-mediated relaxation pathways. Prostacyclin was not likely to be 
involved. Inhibition of the relaxation effect of SAB by treatment with 
L-NAME and ODQ proposed a NO-related relaxation mechanism. However, 
the effect of SAB was only partially abolished by the inhibition of NOS and 
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GC, implying that the action of SAB could also involve other pathways. High 
extracellular K+ completely attenuated the relaxation response of SAB, which 
suggested the involvement of K+ channel. Among the three types of K+ 
channels investigated, SAB mainly acted on Kir and BKca, rather than Kv 
voltage-dependent channels. Interestingly, when the effect of SAB was 
examined in denuded aorta rings, it showed no difference in the vasodilating 
response compared to that of intact rings, indicating an 
endothelium-independent relaxation. Therefore, the main action of SAB is on 
the smooth muscle cells and the putative targets include guanylate cyclase and 
K+ channels. The smooth muscle-mediated effects compensated the decreased 
availability of NO by removal of endothelial and maintained the relaxation 
tone of SAB in denuded rings. Therefore, the action of SAB can be concluded 
to be predominantly endothelium-independent and is mainly acting on the 
vascular smooth muscle. 
Regarding daidzein, the intervention studies indicated that it acted through 
endothelium-dependent relaxation, presummably by the release of NO and 
prostacyclin. Daidzein also acted on the smooth muscle cells by opening the 
potassium channels since the blockage of the channels completely abolished its 
effect. Therefore, daidzein may act through both endothelium-dependent and 
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endothelium-independent smooth muscle cell mechanisms. Daidzein exhibited 
high efficacy in its action at low dosage. The mechanism underlying the 
non-selective but potent action of this pure compound is of much interest but 
remains to be confirmed by further studies, which may shed light on the 
prevention of atherosclerosis. 
Referring DY 80 extract, it could be seen that inhibition in the NO and 
prostacyclin pathways did not change the vasodilatory response of DY 80. 
Therefore the endothelium seemed not to be the crucial factor for its effect. DY 
80-mediated vasodilation was found to be inhibited by the blockage of 
potassium channels, albeit to a partial extent. Therefore, it could be inferred 
that SAB is the active compound which contributed more to the DY 80's effect, 
because of its higher content in the extract when compared with daidzein. In 
the absence of endothelium, the effect of SAB and daidzein on smooth muscle 
cells were able to account for the relaxation response of DY 80. However, it is 
also possible that other compounds could be the active components of DY 80, 
apart from SAB and daidzein. As vasodilation is a complex process, these 
compounds, together with SAB and daidzein, may also act through other 
mechanisms in achieving the relaxation. Other factors, which may mediate 
endothelium-independent relaxation, include the direct inhibitory action on the 
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influx of Ca2+ into the smooth muscle cells and the release of Ca^^ from the 
intracellular stores, inhibition of cyclic nucleotide phosphodiesterase and 
inhibition of protein kinase such as myosin light chain kinase and other kinases 
involved in Ca^^-sensitizing such as protein kinase C, Na+ -K+- ATPase and 
cytochrome 450. However, the following questions remain unsolved in the 
present study. How could daidzein achieve its multi-target actions? What 
makes SAB possible to induce the vasodilation response with potency similar 
to that of daidzein, by predominantly acting on potassium channels only? And 
what will be the explanation for the observation that the action mechanisms of 
daidzein did not reflect in that of the crude extract DY 80? Further in-depth 
study is needed to obtain more understanding about the working mechanism of 
DY 80 and its active compounds on vasodilation, which is enabled by the 
treatment of inhibitors/blockers in combinations, to reconfirm their 
involvement in specific relaxation pathways (NO, PGI2, EDHF, etc). 
Vasodilation property provides a surrogate marker to assess the endothelial 
function of vessels. Normal endothelium embraces anticoagulant, anti-platelet 
and fibrinolytic properties, as well as controls vascular tone and smooth muscle 
cell growth. Endothelial dysfunction contributed to disease states characterized 
by vasoconstriction, excessive thrombosis, abnormal vascular proliferation, 
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hypertension and atherosclerosis. These abnormal endothelial physiologies 
were implicated in both early-stage and advanced-stage atherosclerosis, which 
may be related mainly to the decreased bioavailability of nitric oxide (NO). 
Studies reported that the decreased local availability of NO or excess 
production of superoxide anions was accompanied by endothelial dysfunction. 
NO is a local vasodilator and it can inhibit platelet adherence and aggregation, 
smooth muscle proliferation and leucocytes interaction with endothelium. 
Reduced NO can result in proatherogenic effects even at gene transcription 
level, contributing to the initiation and progression of atherosclerosis. In the 
present mechanistic study, a putative NO-mediated relaxation pathway was 
demonstrated to account for vasodilation effect of daidzein and partially for 
that of SAB. These two active compounds therefore might be able to reverse 
the condition of endothelial dysfunction in patients by restoring NO, providing 
possibility to deter the progression of atherosclerosis. Prostacyclin also plays 
an important role in inhibiting platelet adhesion to endothelial cells. Daidzein 
was also shown possible to increase availability of prostacyclin. All these 
actions might help reversing endothelial dysfunction and promote a healthier 
vessel. It was also reported that impaired endothelium-dependent dilation at 
sites of coronary plaques may result in paradoxic vasoconstriction during 
exercise or mental stress, when vasodilation is mostly needed. Vasodilating 
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effect of these two active compounds may alleviate these high risk acute 
conditions. If these strategies could be implemented early in the disease 
process, it might prevent or retard atherogenesis. Even in advanced stage, 
improvement of vascular health may help decrease chances of thrombosis and 
vasoconstriction, hence decrease the risk of acute cardiovascular events. 
Conclusion 
To conclude, the vasodilation effect of DY 80 extract was 
endothelium-independent and partially acts on opening of IC+ channels. SAB 
acted through endothelium-independent relaxation and on smooth muscle K+ 
channels. Daidzein . acts via endothelium-dependent vasodilation and 
non-selectively through nitric oxide, prostacyclin and EDHF pathways. These 
two active compounds and the crude extract were found possible to increase 
bioavailability of NO and decrease free radical production by their antioxidant 
property, as previously mentioned, may help reverse endothelial dysfunction 
and slower the progression of atherosclerosis. 
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Chapter 5 
Study on Lipid Peroxidation and Uptake by Macrophages 
5.1 Study of DY 80 and SAB on Copper-ion induced Low Density 
Lipoprotein Oxidation 
5.1.1 Pathologic Role of oxidized Low Density Lipoprotein 
Oxidized LDL (oxLDL) plays an important role in the pathogenesis of 
atherosclerosis, both in the early inflammatory stage (Steinberg, 1997) and the 
advanced (Auge et al., 1999) stage of atherosclerotic lesion. Oxidized LDL 
induces foam cells transformation. Besides, oxidation of LDL in subendothelial 
space converts LDL into ligands of the scavenger receptors and the 
receptor-mediated endocytosis of oxLDL may be a primary pathway for the 
cholesterol deposition in macrophages during plaque formation in vivo. 
OxLDL is cytotoxic to endothelial cells and is chemotactic to monocytes, 
increasing their extra-cellular matrix synthesis and promotes platelet 
aggregation (Parthasarathy & Rankin, 1992). 
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5.1.2 Antioxidants in Low Density Lipoprotein and Role of 
Transition Metals 
The main lipophilic antioxidant inside LDL is vitamin E {a -tocopherol) 
which resist ox-LDL formation (Esterbauer et al., 1992) and impair the 
leukocytes superoxide production (Cachia et al., 1998). Any exogenous source 
of antioxidants, which could act together to further resist or delay oxidation of 
these lipoproteins, are considered beneficial in preventing lipid peroxidation 
and relieve atherosclerosis. Lipid peroxidation was induced by Cu^^ in vitro in 
the present study. The presence of transition (e.g. Cu^ '^ Fe^^) metals in 
atherosclerotic lesions has been reported (Lamb et al.., 1995; Stadler et al., 
2004) which may reveal the possible role of transition metals in lipid 
peroxidation. DY 80 extract and SAB were examined in this study for their 
potency to resist Cu^^-induced lipid peroxidation. 
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5.1.3 Methods and Materials 
Preparation of LDL 
Human LDL (Merck, lOmg) was washed by passing through HiTrapTM 
Desalting column (Amersham Pharmacia Biotech, 5ml) to remove EDTA. PBS 
was then used to elute the native LDL. 
LDL Oxidation 
Oxidation was initiated by the addition of CUSO4 (final Cu concentration 
5uM) to the LDL (final concentration lOOug/ml). The formation of conjugated 
dienes was monitored continuously by measuring the increase in absorbance at 
234 nm. The LDL suspension was incubated in a spectrophotometer cuvette at 
37®C for 24 hours. The spectrophotometer was set to zero against the blank and 
the increase in the absorbance during LDL oxidation was recorded every 8 
minutes. The lag time required for the initiation of lipoprotein oxidation was 
determined from the oxidation curve. 
Inhibition of lipid peroxidation by drugs 
Appropriate concentrations of drugs were added to the native LDL before 
the addition of oxidation-initiating agent Cu^^ into cuvettes. Any change in the 
lag time for the formation of conjugated dienes in the presence of drugs was 
compared with the control. 
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5.1.4 Results 
Lag time determination was defined by the end of lag phase which is 
accompanied by the start of propagation phase, as described (figure 5.1). As 
shown in figure 5.2 and 5.3, DY 80 and SAB were found to be able to delay the 
LDL oxidation by shifting the oxidation curve to the right, compared with the 
control without drug. In addition, by doubling the concentration of DY 80 and 
SAB, the lag times of dienes formation were further delayed by two fold, 
showing a dose-dependent effect. 
0.45 
0,4 - 产 
0 , 3 5 - / / 
g 0.2 ^ Lag time f 
0 . t 5 - \ / 
一 — - — — ‘ 十 ‘ ‘ 
0 2 0 0 4 0 0 6 0 0 8 0 0 
T i m e ( m i n ) 
Fig. 5.1 Determination of lag time in Cu^^-induced LDL oxidation model. 
Formation of conjugated dienes was monitored for 24 hours at 234nm 
wavelength. The lag time is defined as the intercept point of the two crossed 
lines. 
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Fig. 5.2 Antioxidative effect of DY 80 and SAB on Cu2+-induced LDL 
oxidation. Data of one of seven trials was shown here. The lag time for the 
trial was determined as oxLDL (control) 128min, DY 80 (ljug/ml) 632min, DY 
80 (0.5fig/ml) 320mm, SAB (O.lpig/ml) 536min and SAB (0.05ng/ml) 288min. 
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Fig. 5.3 Deferral of Lag Time for coupled diene formation by DY 80 and 
SAB on Cu^"^-induced LDL oxidation. Average lag time for coupled dienes 
formation with drugs or without drug were presented. Data were expressed as 
mean 土 SD (n=7).林 P<0.001, compared with control. Both concentrations of 
DY 80 and SAB were found able to delay the lag time for dienes formation. 
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5.1.5 Discussion 
Free radicals are generated elsewhere in the body and can cause lipid 
peroxidation. For example, superoxide anions are generated from 
xanthine/xanthine oxidase in the endothelial cells. Mitochondria are also an 
important source of oxygen free radicals. Free radicals are also formed in 
leukocytes, and during the oxidation of catecholamines. Oxidized LDL is 
capable of a wide range of toxic effects. OxLDL activates inflammatory 
processes at the level of gene transcription by up-regulation of N F - K B , 
expression of adhesion molecules, and recruitment of leukocytes, hence 
increases endothelial cell adhesiveness towards monocytes (Lamb et al., 1995; 
Steinbrecher et al., 1990). It also promotes vascular smooth muscle cells 
proliferation (Auge et al., 1999a). OxLDL can inhibit the production of nitric 
oxide (NO), and induces vessel wall dysfunctions that are characteristically 
associated with development of atherosclerosis. Therefore, resisting oxidation 
of lipoproteins may lead to the possibility of relieving endothelial dysfunction 
by reducing loss of NO. 
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SAB has been identified previously as antioxidants, belonging to the group 
of polyphenols. Polyphenols are known to be antioxidant and protect other 
antioxidants in the biological fluids and LDL in vivo (Carbonneau et al., 1997; 
Cartron et al., 2001). Drug treatment with either DY 80 extract or SAB both 
significantly reduce the rate of lipid peroxidation in this in vitro study, which 
may further suggest their putative anti-atherogenic effect in the prevention of 
cardiovascular disease and add values to this herbal formula, as preventing 
LDL oxidation is a critical step in deterring atherosclerosis, especially at early 
stages. 
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5.2 Study of Scavenger Receptor Regulation in Macrophages 
5.2.1 Introduction 
Peroxidation of low density lipoprotein and subsequent excessive uptake of 
the oxidatively-modified LDL via the scavenger receptor into macrophages are 
believed to play an important role in atherogenesis (Esterbauer et al., 1997). It 
is recognized that several types of scavenger receptor proteins are expressed on 
the macrophage surface, including SR-A type I, II and III, MARCO, CD36, 
SR-BI, CD68, LOX-1, PSR and SR-PSOX (Kodama et al., 1990; Greaves et al., 
1998; Ottnad et al., 1995). SR-A type I and type II are the first identified 
members of the scavenger receptor family (Rohrer et al., 1990; Kodama et al., 
1990). Several studies have documented important roles of SR-A in 
atherosclerosis. Marked reduction in atherosclerosis was demonstrated in mice 
lacking the gene encoding SR-A (Babaev et al., 2000). Macrophages lacking 
both SR-A and CD36 have 80 - 90% reduction in the internalization and 
degradation of either acetylated or oxidized lipoproteins (Kunjathoor et al., 
2002). Therefore, the effect of DY 80 and SAB on the SR-A receptor 
expression was evaluated in this study. 
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5.2.2 Methods and Materials 
THP-1 cell line 
Human peripheral blood acute monocytic leukemia cell line THP-1 was 
obtained from American Type Culture Collection (ATCC, Roctvile, MD, USA). 
Cells were grown in suspension at 37�C in 5% CO2, 95% air in RPMI 1640 
medium containing 10% fetal bovine serum (FBS) (v/v) (GIBCO-BRL). Cells 
were plated and differentiation was induced by 60nM PMA co-incubation for 
72 hours before used in experiments. The cells were then incubated with or 
without lipoproteins (lOOug/ml) and drugs. 
Oxidized LDL and drugs preparation/treatment 
Oxidized LDL was prepared by incubating freshly prepared LDL 
(600|ig/ml) as mentioned in previous section, with 30|xM C11SO4 at 37"C in 
dark for 24 hour. DY 80 extract and SAB were suspended in the medium at 
appropriate concentrations. Both oxidized LDL and drugs were micro-filtered 
to remove contaminants before co-incubation with THP-1 cells. Final 
concentration of oxidized LDL in plate was 1 OO^g/ml with DY 80 or SAB. The 
plates were kept in 5% CO2, 37®C incubator for 48 hours before protein 
extraction. 
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Protein preparation 
After drug treatment, the medium was discarded. Cells were washed and 
trypsinized, collected by centrifugation at 1000 x g for 3 minutes. Cell pellet 
was then washed with PBS before lysing in 30-50|il lysis buffer (ImM 
Phenylmethylsulfonylfluoride, 1% Triton X-100, 21 |ig/ml Aprotinin, 0.5 
|ag/ml Leupeptin, 4.9 mM MgCli and 1 mM Vanadate) on ice for 2 hours with 
frequent mixing to ensure complete lysis reaction. Cell lysates were then boiled 
at IOQOC for 10 minutes. After centrifugation, supernatant was collected and 
stored at - 7 0 �C until use. Protein concentrations were determined by 
bicinchonic acid (BCA) assay (Sigma, USA). 
Western Blotting 
Equal amounts of proteins (30|ig) were separated by 12.5% SDS-PAGE 
and transferred onto nitrocellulose membrane using Trans-Blot apparatus 
(Bio-Rad). After blocking with 10% non-fat milk for 1 hour at room 
temperature and washed three times TBS-T, each for 15 minutes, the 
membrane was incubated with primary antibody (Anti-SR-A, Chemicon 
International, Temecula, CA) with 1:1000 dilution at room temperature for 1 
hour. The membrane was then washed three times with TBS-T, each for 15 
minutes and incubated with anti-goat secondary antibodies which conjugated 
- 1 3 7 - • 
Chapter 5 Study of Scavenger Receptor Regulation 
with horse-radish peroxidase at 1:1000 dilution (Santa Cruz, USA) at room 
temperature for 1 hour. After washing, the membrane was visualized by 
chemiluminescence reagent of ECL system (Amersham Life Science, UK) and 
then exposed to X-ray film. The protein bands were normalized to unit actin 
(stained by anti- /3 -actin antibody (Sigma, USA) with 1:5000 dilution in 
primary antibody blotting and 1:1000 dilution in anti-mouse secondary 
antibody). 
- 1 3 8 -
Chapter 5 Study of Scavenger Receptor Regulation 
5.2.3 Results 
Study of SR-A scavenger receptor protein expression on macrophages was 
presented in figure 5.4. Up-regulation of SR-A expression was found to be 
induced by oxidatively modified LDL. When macrophages and oxidized LDL 
were co-incubated with DY80 extract or SAB, they showed a significant 
down-regulation of the SR-A protein expression on macrophages. Two 
different concentrations of DY 80 and SAB were examined, however, they did 
not show obvious dose-dependent effects. 
oxLDL - + + + + + 
DY 80 - + + - -
(mgtol) (0.01) (0.1) 
SAB - - - - + + 
(mgtol) (0.001) (0.01) 
Fig 5.4 Western Blot of Scavenger Receptor A expression on THP-1 
derived macrophage. Anti-SR-A antibody was used to probe the SR-A protein 
(molecular size: 75kDa) expression in cell lysates. “+，，and “-，，represented 
the presence or absence of specific agents respectively. lOOjug/ml oxidized LDL 
was co-incubated with drugs, DY 80 and SAB at different concentrations. MTT 
cell viability assay did not show toxicity effect by oxidized LDL or by DY 80 
and SAB to cells for two day-incubation. P-actin was used for normalization. 
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5.2.4 Discussions 
Normal macrophages express very few LDL receptors of classical type. 
And it was found that LDL after modification, loses its ability to bind to 
classical receptors. They are instead, recognized by another high-affinity 
receptor, the scavenger receptors, which bind oxidized and acetylated LDL and 
uptake into macrophages (Brown & Goldstein, 1983). Scavenger Receptor 
Type A (SR-A) was found to be the most important class. SR-A gene knockout 
mice bred either on atherosclerosis-susceptible apolipoprotein E (apoE) 
knockout mice or LDL receptor knockout mice showed marked reduction in 
the size of atherosclerotic lesions (Sakaguchi et al., 1998; Suzuki et al., 1997). 
In the present study, at both tested concentrations of DY 80 and SAB, 
marked suppression of the SR-A expression was observed, with no obvious 
dose response being exhibited. This may be due to the fact that the 
concentrations used in this test were too high for generating a significant 
dose-dependent effect. The effect of lower concentrations of the drugs should 
be further studied. The result of the present study suggested that DY 80 extract 
and active compound SAB, which have shown inhibitory activity on LDL 
oxidation, might be able to suppress also the scavenger receptor expression on 
macrophage surfaces, and hence reduce oxidized LDL uptake into 
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macrophages and inhibit foam cells formation. 
Nevertheless, originally detected on macrophages (Gowen et al., 2000), 
SR-A is also present on other cell types, including smooth muscle cells and 
endothelial cells (Bickel et al., 1997). SR-A was found to have other biological 
properties that could impact the atherosclerotic process. One of these recently 
defined properties is its adhesion to lymphocytes (Yokota et al .�1998). The 
adhesive property may be particularly prominent in regions of damaged 
extracellular matrix (Gowen et al., 2000), as this would be expected to occur 
during inflammatory processes within atherosclerotic lesions. Apart from the 
pathology involved by SR-A expression, it was found that the total uptake and 
accumulation of LDL in macrophages may also be achieved via 
non-receptor-mediated pathway by which foam cells could form in vivo 
(Moore et al., 2005; Kruth et al., 2005). Previous studies have shown that 
enzyme modifications by exposing LDL to secretory phospholipase A2 can 
convert native LDL into a structure that can readily trigger foam cell formation 
and hence facilitate atherosclerosis (Zalewski & Macphee, 2005). On the other 
hand, study has showed that the role of SR-A deficiency in atherogenesis may 
be complicated by the presence or absence of apoE in very low density 
lipoproteins (vLDL) in vivo (de Winther et a l , 1999). Overall the molecular 
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mechanism by which SR-A function is regulated remains unclear. Therefore, 
although our drugs could suppress SR-A expression on macrophage in vitro, 
the overall effect of DY 80 and SAB on the oxidized LDL uptake in vivo 
remains to be further elucidated. 
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Chapter 6 
General Discussion 
Cardiovascular disease is a prevalent disease in the century and is 
complicated by multiple factors. These factors are inter-connected that they 
accelerate the process of atherogenesis. Among the few properties investigated 
in this project, experimental evidence showed that the deficiency of one factor 
may affect the others. Reduced availability of NO in endothelial dysfunction 
contributes to the pathogenesis of atherosclerosis, and this reduction of NO can 
be mediated by oxidized LDL, or excessively consumed by superoxide radicals 
and other sources of reactive oxygen species. Oxidized LDL also reduces 
endothelial NO release through its effects on eNOS activity and gene 
expression, and scavenges NO or EDHF directly (Blair et al., 1999; Chin et al., 
1992). Therefore, the oxidative stress and decreased bioavailbility of NO are 
closely related in accerlerating the progression of atherosclerosis. 
In the present study, the 80% ethanol extract of Danshen-Yege formula and 
salvianolic acid B, being an active compound isolated from Danshen, showed 
potent antioxidant activity. The antioxidant action can protect low density 
lipoprotein from oxidation and thus inhibit the progression of atherosclerosis. 
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At the same time, daidzein, being an active compound present in Yege, showed 
vasodilation property in isolated aortic rings, presumably through the 
enhancement of NO release, which propose its possibility of restoring NO level 
in vivo. DY 80 and SAB, though act mainly via hyperpolarizing smooth muscle 
cells, may contribute to the reduction of severe hypertension in NO 
pathway-impaired patients. These multiple effects of Danshen-Yege herbal 
extract may be beneficial in preventing the development of atherosclerosis. 
In addition to the present study, studies from our laboratory has 
demonstrated the cardiotonic effects of the Danshen-Fenge water extract, 
showing anti-proliferative effect against PDGH-induced proliferation and 
anti-migratory effect against platelet-derived growth factor-induced migration 
vascular smooth muscle cells in vitro model and anti-atherosclerotic effect in 
vivo, by exhibiting hypocholesterolemic effect on diet-induced hyperlipidemia 
in rabbit model and inhibiting the atheroma formation (Koon, 2006). A study 
from our Australian collaborates also showed that the formula could decrease 
foam cell formation by modulating acetylated LDL uptake, but in contrast to 
most studies, the extract increased the level of adhesion molecules in vitro 
(Sieveking et al., 2005). Furthermore, a clinical study indicated that the 
treatment with Danshen-Fenge water extract could improve several 
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atherosclerotic markers, including the lipid profile (total cholesterol and 
LDL-cholesterol amount) and vascular functions (flow-mediated brachial 
artery endothelium-dependent dilatation, nitroglycerin-induced dilatation and 
carotid intima-media thickness), in patients suffering from coronary heart 
disease (Tarn, 2004). The homocysteine and adhesion molecules profiles of the 
patients were also monitored, however, no significant change was observed in 
the treatment group patients compared with placebo group. 
Although pharmacological studies have suggested the therapeutical 
application of Dashen-Gegen formula in the prevention/treatment of 
atherosclerosis, the clinical efficacy has yet to be confirmed. Besides, the use 
of ethanol in the extraction process and Yege species in the formulation were 
found to produce a better pharmacological profile in preventing atheroslcerosis. 
However, further studies are needed to assess its effect in vivo and possibly in 
clinical trials in the future. Apart from the active ingredients, whether the 
ethanol extraction also yields more toxic products from the herbs at the same 
time remains to be determined. Furthermore, although the 80% ethanol extract 
showed good anti-atherogenic properties, whether this can be translated into 
clinical improvement remained to be tested by large scale clinical trials. Lastly, 
the development of atherosclerosis begins in youthful age, and progress rapidly 
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in prevalence during 15-34 of age (Strong et al., 1999). Therefore, although 
clinical symptoms of atherosclerosis are not usually manifested until later years 
of adulthood, primary prevention should begin in early age. As such, the use of 
Chinese herbal medicine, like Danshen-Gegen formula, may be warranted. 
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